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1: Research Motivation 
 
 
 There are currently >900 antimicrobial peptides (AMPs) isolated from multi- and 
single cellular species that are active against bacteria
4
, fungi
5
, cancer cells
6
, and viruses
7
.  
The original purpose of isolating antimicrobial peptides from specimens was to replace 
the aging supply of antibiotics that have been plagued by bacterial resistance
8
.  
Antibiotics work best against actively-reproducing planktonic bacteria
9-11
.  DNA and cell 
wall formation will be disrupted by antibiotics, and therefore enabling the body‟s 
immune system to overcome an infection.  In the past few decades, scientists have 
learned of growing bacterial resistance to once easily-treatable diseases such as 
tuberculosis, meningitis, and gonorrhea
12-14
.  Now it is common for a first-line 
prescription antibiotic to be ineffective, requiring more powerful antibiotic prescriptions 
and, at times, leaving doctors without an effective treatment
15-19
. 
 Beginning in the 1980‟s, research began in earnest to better understand peptides‟ 
role in the immune system of multicellular organisms
20, 21
. From the cecropia moth in 
1981
22
, and later pig intestine
23
, scientists isolated what became known as cecropin 
peptides, which are cationic and alpha helical in structure
24, 25
.  AMPs are typically chains 
of 19-82 amino acids and were subsequently discovered in single cellular organisms, 
such as bacteria, and multicellular organisms
26
. 
 AMPs have maintained effectiveness over millions of years of evolution against 
bacteria, viruses, and fungi, which makes them attractive as antibiotics
2, 26
.  General 
commercialization is years or decades away, but nisin, for example, is a peptide that was 
approved in 1988 for use as a food preservation
27-29
.  Some characteristics that hamper 
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product development of AMPs are that they can lead to hemolytic activity
30
, and data 
suggests that they are most effective against insurgent microbes when a variety of AMPs 
are present
31-33
. 
 While research is ongoing with respect to antibiotic substitutions, we have 
recognized a different potential for AMPs; development of a novel biosensor.  
Biosensors, for the most part, use antibodies or nucleic acid detectors that bind to specific 
locations on the host cell
34, 35
.  Although still under development, nucleic acid detectors 
lack batch-to-batch consistency and are extremely expensive to implement.  Our 
approach differs in that we are employing AMPs, specifically cecropin P1, as the cellular 
marker. 
 The need for reliable biosensors has been illustrated by the numerous Escherichia 
coli outbreaks associated with meats and fresh produce.  E. coli O157:H7, identified as 
the culprit in the 1982 outbreak of dysentery in the United States
36, 37
, has been associated 
with recent food recalls such as the fall 2006 recall of spinach
38
 and numerous other 
ground beef recalls in the United States such as a 1997 recall of beef patties from 
Colorado
39
, 2000 outbreak of E. coli O157:H7 in Minnesota
40
, and continues to be found 
in ground beef samples
38, 41, 42
. 
 The effectiveness of AMPs has been well documented against pathogens; 
however, relatively little is understood regarding their underlying mechanisms of action 
against bacteria.  Although creating an AMP biosensor to detect E. coli O157:H7 would 
be a breakthrough, we seek to take a step further and discover how AMPs interact with 
bacterial lipopolysaccharides (LPS) that have been well characterized in terms of core 
polysaccharide groups and O-antigen structures. 
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 By immobilizing cecropin P1 (CP1) to silicon nitride and gold (CP1-cys), we 
measured the binding forces between bacteria and peptides, and explored important 
bacterial features such as LPS composition and length that influence binding affinity with 
CP1.   The structure of the LPS is comprised of 3 sections: lipid A, core group, and O-
antigen.   We are mostly interested in the initial binding between AMP and LPS since our 
goal is to develop a novel biosensor that can detect pathogenic bacteria within seconds of 
exposure.  Considering the short exposure period, the AMP would only be exposed to the 
O-antigen and outer core groups, which are repeating sugar chains that are essential for 
bacterial pathogenicity and adhesion to substrates.  Although geared for use as a novel 
biosensor, results of this study can also be applied to the using AMPs for replacing or 
enhancing the activity of antibiotics.  Our work suggests that CP1 may not be serotype 
specific, but targets the O-antigen before interfering with phospholipid groups of the 
bacterial membrane.  Other factors that assist in pathogenicity, such as LPS length, may 
also be important for consideration of CP1 potency. 
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2: Literature Review 
2.1: The Biofilm 
 Bacteria may be found in two separate forms; planktonic (i.e. free in suspension), 
and as part of biofilm.  In nature, 99.9% of bacteria are found within biofilms
43
.  Biofilms 
are commonly thought of as 3-dimensional matrices consisting of 75% to 95% „slime‟ 
with the remainder being the cells
44
.  The slime is most important for the survival of the 
bacteria, and in certain cases, toxic for the host.  The slime acts as a shield against 
antibiotics, environmental stresses, and bodily defenses, making it the pristine 
environment for bacteria to thrive
44
. 
 The „slime‟ is different for each type of bacterium, consisting largely of 
negatively charged and neutral polysaccharide groups
44
.  The polysaccharides give the 
„slime‟ its sticky characteristics that attach cells to substrates and each other.  Indwelling 
charges are important for ion exchange between cells in the biofilm.  This is important for 
trapping and distributing food, such as iron, within the biofilm so that the cells do not 
starve.  In some environments, such as water distribution systems, cells have 
demonstrated an amazing ability to survive given a limited nutrient environment of only 
trace amounts of iron and other organic compounds
45
.  
Two main molecular groups, polymeric carbohydrates and polymeric proteins, 
have been shown to promote bacterial retention to substrates.  In the case of S. 
epidermidis, two prominent polysaccharides have been identified including capsular 
polysaccharide (PSA) and polysaccharide intercellular adhesion (PIA)
45
.  The accessory 
gene regulator (agr) system influences both biofilm dispersal and attachment of cells to 
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surfaces, but does not regulate PIA expression
46
.  Studies have shown that disrupting the 
agr locus of S. epidermidis results in superior adhesion to polystyrene, increased biofilm 
formation, and increased expression of the AtlE gene that enhances attachment to abiotic 
surfaces
45
.   
 Once attachment occurs, phenotypic changes alter protein expression within the 
cell in a matter of seconds; thus initiating the biofilm
45, 47
.  The proteins irreversibly 
anchor the bacteria to the surface.  Within 12 minutes, cells begin accumulating proteins 
and polysaccharide slime that further bond the cells to the substrate and to other cells 
within the matrix
45
.  The biofilm grows in an upwards motion as daughter cells are 
created through further division.     
 Eventually, the biofilm may grow as high as 60 μm before shear stresses in the 
bloodstream break off sections of the biofilm
48
.  It is also suspected that cell-to-cell 
signaling may provoke this detachment in order to keep cells at the bottom of the biofilm 
from starving.  Alginate lyase is one such component that has been shown to cause early 
detachment of bacteria from a biofilm
49
.  Other factors including pH, rate of oxygen 
uptake, electron transport, and heat production may also be useful for signaling to 
bacteria that a biofilm is overly mature
50
.   
2.2: LPS and Serotpying E. coli 
2.2.1 Importance of E. coli Lipopolysaccharide 
 Recent E. coli outbreaks in spinach and meat products have demonstrated the 
continuing threats posed by pathogenic E. coli
38, 41, 42
.  However, E. coli are ubiquitous in 
nature and most E. coli are harmless and are necessary for human digestion
51
.  E. coli 
harbor in the gut tract and consume nutrients supplied during the digestive process.  E. 
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coli O157:H7 differ from most E. coli by causing severe diarrhea and dysentery in 
humans.  Farm and wild animals are believed to be the sources of most E. coli O157:H7 
outbreaks.  For instance, when fresh produce is contaminated with E. coli O157:H7, the 
bacteria can usually be traced from fecal matter of nearby animals
52-54
.   Cows test 
positive for E. coli O157:H7 the most among farm animals
55
, but sheep, poultry, and pork 
can also be carriers of E. coli O157:H7
56
.   
 Testing for pathogenic E. coli includes serotyping of the O-antigen, which for E. 
coli O157 and O113 usual indicates severe symptoms of dysentery for the infected
57-60
.  
O-antigen is an important indicator for determining if an isolated E. coli strain is 
pathogenic, however, the role that the O-antigen has for initiating infection remains 
unclear.  For instance, E. coli O157 is synonymous with widespread foodbourne 
outbreaks
61-63
 and uropathogenic E. coli tend to be of the serotpyes O4, O6, O14, O22, 
O75, and O83
64
.  However, there are no universal relationships between serotype and 
pathogenicity.   
 LPS is comprised of the lipid A that extends from the bacterial membrane, 
followed by a conserved inner and outer core, and a repeating O-antigen chain
65-67
 
(Figure 2.1).  The lipid A is a known toxin to epithelial cells
68, 69
.  Through a 3-deoxy-d-
manno-octulsonic Acid (kdo) bond, the lipid attaches to the sugar groups of the core 
polysaccharide, but there is a lack of understanding regarding how the lipid binds to the 
bacterial membrane
70
.  Saturated fats comprise nearly all of lipid A, along with 
phospholipids that give the bacteria a negative charge
67
.  The fatty acids C12OH and 
C14OH have been reported as being the most toxic components in lipid A
68, 69
.   Antibiotic 
treatments against E. coli O157:H7 can hasten bloody diarrhea by disrupting bacteria  
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Figure 2.1 Schematic of the bacterial LPS for E. coli strains.  A. The bacterial membrane 
is attached to Lipid A, followed by the inner core, and outer core.  Rough bacteria will 
have no O-antigen.  Semi-rough bacteria have an O-antigen, but it is not a repeating unit.  
Smooth bacteria, which comprise the overwhelming majority of bacteria, have a 
repeating O-antigen.  B. Shematic of the K12 core group.  Neutrally charged and 
comprised of sugars, the O-antigen may attach to the core group for smooth and semi-
rough strains.   
 
 
A 
B 
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membranes and releasing deadly levels of lipid A into the body
71, 72
.  Antibiotic regimens 
that target lipid A synthesis, followed with common treatments such as penicillin, have 
be shown to be more effective
73
.    
 The O-antigen of >180 E. coli strains have been well characterized
74
.   O-antigen 
is used for serotpying E. coli and is important for adhesion to host cells.  The O-antigen is 
a polysaccharide with repeating units of 1 to >100
75, 76
.  Rough bacteria are common 
laboratory strains lacking the O-antigen.  Semi-rough bacteria are less commonly found, 
having one unit of the O-antigen, and smooth bacteria are the most commonly found, 
which express repeating O-antigen units
77
.  The LPS core and O-antigen are key 
components that mediate bacterial binding with substrates and enable aggregation with 
other cells
78
.  The O-antigen assists E. coli binding through hydrogen binding
79
 and can 
self-aggregate
67, 80
.  While the O-antigen is known to be important for E. coli pathology, 
the evolutionary advantages of the numerous O-antigens remains unclear.    
Analysis of bacterial O-angtien is used for serotyping different bacterial strains.  
For example, E. coli species have >180 designated O-antigens, from O1A to O178
81
.  The 
LPS core and O-antigen are key components that mediate bacterial binding with 
substrates and enable aggregation with other cells
78
.  Beyond lipid A, the LPS is 
comprised of sugar molecules that, through hydrogen bonding, firmly bind the bacteria to 
substrates
79, 82
 and can self-aggregate
67, 80
.   
 For E. coli, there are five outer core groups known as K12, R1, R2, R2, and R4.  
Figure 2.1 A illustrates the differing sections of the LPS, while Figure 2.1 B shows the 
sugars of the K12 core.  These sugar chains are constrained to the outer potion of the core 
LPS and connect to the O-antigen, although the exact point where this connection occurs 
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is not understood for all strains
1, 68, 69
.  Bacteria lacking the O-antigen are non-pathogens 
and cannot survive outside a laboratory setting
83
, which raises the question concerning 
the role the O-antigen plays in bacterial virulence.  Considering the sources of toxicity 
and negative charge among E. coli strains are derived from the lipid A, it is likely that the 
O-antigen is used for initial adhesion to host cells and substrates
78
. 
2.2.2 Expression of Shiga-like Toxins 
 Pathogenic E. coli exert toxins identified as shiga-like toxins, which have been 
linked to symptoms of dysentery
72, 84-86
.  Cattle are resistant to shiga toxins, possibly due 
to lack of binding spots on enterocytes and blood vessels
87
.  Rabbits are 1,000-10,000 
more susceptible to shiga toxins than species such as cattle, rats, and guinea pigs
85, 88
.  
Also, intimins on the bacterial membrane have been identified in enteropathogenic E. coli 
(EPEC) and enterotoxigenic E. coli (EHEC) and these proteins may also be toxic for 
humans
89-91
. 
   True shiga toxins are derived from the bacterium Shigella dysenteriae and are 
very similar to toxins produced by E. coli
84-86
.  Testing for shiga toxins is a common 
method for identifying pathogenic bacteria.  Shiga-like toxins are produced through the 
stx gene pathway
87, 92-94
, whereas the gene eae is essential for attaching the bacterium to 
the gut tract
95-97
.  The stx and eae genes are present in most pathogenic E. coli and are 
usually expressed by E. coli of select serotypes such as O157
98, 99
.  One of the most 
commonly employed methods for identifying a bacterium is by characterizing the O-
antigen.  Serotpying identifies E. coli in terms of the O-antigen, flagella antigen, and 
capsular antigen
65
.  Bacterial lipopolysaccharide (LPS) is one of the most important 
components that determine bacterial pathology.  For instance, E. coli O157 is 
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synonymous with widespread foodbourne outbreaks
61-63
 and uropathogenic E. coli tend to 
be of the serotpyes O4, O6, O14, O22, O75, and O83
64
.           
Stx I was first identified by Konowalchk et al. in 1978,
100
 and is estimated to have 
a molecular weight of 70,000
85
.  Subunits of Stx I and a related toxin Stx II (VT1-A, VT2-
A, and 5 subsequent B polypeptides) have revealed some of the mechanisms for 
pathology. For instance, rabbits were discovered to be amongst the most vulnerable 
species to stx I & II, whereas monkeys, hamsters, mice, rats, and guinea pigs were 5, 40, 
700, 5,000, and 10,000 times more resistant to the toxics effects
85, 88
.  Researchers have 
therefore focused efforts on why rabbit cells are especially susceptible to stx and how 
guinea pig cells resist the toxic effects. 
Rabbit cells, being among the most sensitive to shiga toxins, have been subjected 
to numerous studies with the goal of determing whether toxins disrupt host cellular 
functions or promote adhesion for the invading E. coli.  Robinson et al. found that an E. 
coli O157:H7 stx1-/stx2+  strain had marked improvement to binding to rabbit cells over 
the isogenic E. coli O157:H7 stxI-/stxII- (TUV86-2).  When stxII was inoculated onto the 
host cell prior to treatment with TUV86-2, comparable adhesion was observed
101
.  These 
results compare well with prior studies of stx, and may provide a target for treating E. coli 
infections
38
.   
 
Each E. coli O157:H7 isolate can produce different toxins or none at all.  For 
instance, when testing for E. coli O157:H7, it is common to include an analysis of the 
toxins that the isolate produces
102, 103
.  In addition to serotyping in terms of O, K, and H, 
E. coli can be classified on basis of symptoms that they cause.  Detecting E. coli 
2.2.3 E. coli Diseases 
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producing shiga toxins is a superior method for determining the threat posed by an 
isolated strains
103
.  The classes of E. coli pathogens include enteropathogenic E. coli 
(EPEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), 
enterohaemorrhagic E. coli (EHEC), enteroaggregative E. coli (EAEC), diffusely 
adherent E. coli (DAEC), and uropathogenic E. coli (UPEC)
104
.  Table 2.1 lists some of 
the E. coli strains that lead to these infections.   
EPEC:  E. coli were first described as potentially virulent in 1945 by Dr. Bray 
when an E. coli outbreak of among children under 5 who had symptoms of watery 
diarrhea, vomiting, and low-grade fever. Since the time of this outbreak, improved food 
safety protocols and sanitation have made similar outbreaks significantly less common 
among developed countries, however, outbreaks remain common among inhabitants of 
poorer nations
105-107
.  
ETEC:  Symptoms of ETEC are normally mild and brief when compared to most 
other E. coli infections.  Infection usually occurs through contaminated water, but can 
spread through contaminated fresh produce.  ETEC is often called the “traveler‟s 
diarrhea” since the local population in a less developed nation may be immune from the 
bacteria causing disease
108
. 
EIEC:  More severe than EPEC and ETEC, EIEC often leads to dysentery, or 
watery diarrhea.  EIEC during diagnosis is often mistaken with Shigella spp. and often 
occurs in random outbreaks.  Bacillary dysentery can occur if EIEC occurs in concert 
with a Shigella spp. infection, which is described as a combination of mucus and blood in 
the stool
104
.    
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EHEC: Is the most severe E. coli infection that readily renders the elderly and 
neonates with kidney failure, dysentery, and can lead to death within days or weeks of 
infection.  EHEC is associated with either stxI, stxII, or a combination of toxins.  Through 
the eae gene, bacteria mitigate adhesion to the colon and small intestine where internal 
lesions develop.  Unfortunately, antibiotics have been found to worsen symptoms by 
summarily releasing potently toxic levels of stx.  Treatments against EHEC are thereby 
limited to hydrating the patient until the bacteria are purged from the body.  EHEC have 
caused large outbreaks in both industrialized nations, such as the United States, and 
poorer nations where bacteria associated with ETEC commonly occur. All EHEC 
bacteria are pathogenic to humans regardless of repeated infection
104
.  
EAEC:  A significant emerging disease in pediatric medicine, bacteria involved in 
EAEC are persistent pathogens, which often infect children <5 years of age.  EAEC do 
not secrete enterotoxins, but instead adhere to HEp-2 cells
104, 109
.  Although not 
associated with dysentery, mucosal damage does occur and symptoms can last for weeks 
at a time. 
DAEC:  Diffusively attached bacteria to animal cells occur through surface pili, 
but little is known about which serotypes cause DAEC.  Patients with DAEC often have 
symptoms of watery diarrhea but do not  have bloody diarrhea
110
.  Similar to most other 
E. coli, children <5 years of age are most susceptible to infections with DAEC. 
UPEC:  The most common E. coli infection occurs in the urinary tract, which is 
called a urinary tract infection (UTI).  Type 1, type P, and other pili significantly aid in 
the adhesion of E. coli to uroepithelial cells
64
.  UPEC are readily treatable with antibiotics 
and the disease is rarely fatal unless bacterema develops.  Severe infection can lead to 
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kidney failure and disease is commonly associated among neonates, the elderly, and 
women.   
Table 2.1 E. coli Pathotypes Associated with Verified O-antigens104, 111 
Pathotype EPEC ETEC EIEC EHEC EAEC DAEC UPEC 
O-antigen O18ac, 
O20, O25, 
O26, O44, 
O55, O86, 
O91, 
O111, 
O114, 
O119, 
O125ac, 
O126, 
O127, 
O128, 
O142, 
O158 
O6, O8, 
O11, O15, 
O20, O25, 
O27, O78, 
O128, 
O148, 
O149, 
O159, O173 
O28ac, 
O29, 
O112ac, 
O124, 
O136, 
O143, 
O144, 
O152, 
O159, 
O164, 
O167 
O4, O5, 
O16, O26, 
O46, O48, 
O55, O91, 
O98, 
O111ab, 
O113, 
O117, 
O118, 
O119, 
O125, 
O126, 
O128, 
O145, 
O157, 
O172 
O3, O7, 
O15, O44, 
O77, O86, 
O111, 
O126, 
O127 
O8, 
O17, 
O26, 
O55, 
O86, 
O95, 
O119, 
O128 
O4, O6, 
O14, 
O22, 
O75, 
O83 
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2.3: Antimicrobial Peptides 
 The concept of using AMPs for medicinal purposes is >30 years old, and has 
caused significant excitement as over 900 isolates have been identified
2
.  Antimicrobial 
peptides are found in every investigated single-cellular organism, to more complex 
species including plants and animals
112
.  Numerous peptide isolates are commonly 
derived from multicellular species such as toads, moths, pigs, and more
113
.  Every species 
offers unique peptides, which is an indication that the discovered AMPs represent less 
than 1% of the total in nature.   
 AMPs generally have a cationic charge ranging from +2 to +9, and charge is an 
underlying mechanism that enables binding with bacteria
26, 112, 114-121
.  The bacterial LPS 
structure contains anionic phospholipids that have made bacteria evolutionarily 
vulnerable to AMPs
114, 121
.  Hence, antibacterial peptides are positively charged with few 
exceptions
114, 121
. 
 Eukaryotic cells have membranes comprised of zwitterionic and neutral lipids.  
Phosphatidylglycerol is the main component for such cells
122
, while prokaryotes have 
acidic phospholipids that include phosphatidylglycerol, Phosphatidylserine, and 
cardiolipin
121
.  Surface charges of eukaryotes are generally lower than those of bacteria, 
which assists AMPs in targeting pathogens. 
 AMPs come in various shapes but mostly fall into one of two structural categories 
(Figure 2.2) 
a. α-helical/linear 
b. β-sheet/disulfide stabilized  
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Rarer structures include extended helices and cyclized loops.  Whether the AMP is of 
these two forms does not appear to determine the mechanism of cellular action
123
, 
although continuing research may eventually prove otherwise.  In addition, charge, 
hydrophobicity, and length were nonfactors for AMP activity against P. aeruginosa and 
Escherichia coli
124
.   Indeed, studies hereto forth have failed to identify ligand-receptors 
between AMPs and bacteria
123
.    
 
Figure 2.2 A. α-helical/linear B. Cysteine stabilized α- β-sheet  
(Adapted from Yount, et al.
2
) 
 
 A study conducted by Matsuzaki et al. measured zeta potential changes that occur 
when the cationic AMP Tachyplesin I acetamidomethyl and L-α-phosphatidylglycerol are 
present on membranes
125
.  For every 20 mV decrease in the zeta potential of the 
membranes, the AMP was 200 times more favorable to attach
2, 125
.  Considering the near-
neutral charge of mammalian cells and zeta potentials of bacteria of -30 mV, there is 
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strong data eluding the preferential binding of AMPs to bacteria versus host mammalian 
cells. 
 One of the most traditional methods for discovering antimicrobial agents is to use 
zones of inhibition on agar plates.  For example, Chen et al. inoculated Brucella broth 
plates with the AMP odorranain-HP to test against H. pylori, S. aureus, E. coli, B. 
dysenteriae, and C. albicans
116
.  Minimal inhibitory concentrations were determined 
against each strain, which were 20, 5, 30, 30, and 25 μg/mL for the aforementioned 
bacteria, respectively
116
.   
2.3.1 Bacterial Resistance to AMPs  
 While rare, bacterial resistance to AMPs has been discovered in both Gram-
positive and Gram-negative strains.  Studies have demonstrated that alterations in charge 
of the lipid A region of the LPS have significant effect of whether the AMP kills the 
bacteria.  Peschel et al. has found that expression of the mprF gene in S. aureus and E. 
coli led to the positively charged L-lysine to be suppressed in the lipid A region
126
.  
Bacteria expressing this gene were more susceptible to AMPs than those without the 
gene
127
.  The PagP gene that causes acylation of the lipid A was found to have a 
significant affect for AMP permeability in Legionella pneumophila
128
.  The degradation, 
efflux, and external trapping are some other proposed mechanisms that may assist 
bacteria to resist AMPs
127
.   
 Among S. aureus strains, an exoprotein called staphlyokinase is expressed and 
released; activating host plasminogen
127
.  In addition to this process, Jin et al. found that 
staphlyokinase also binds to the α-definsins produced by mammalian cells129.  When the 
dlt and mprF genes, which are responsible for generating the α-definsins, were not 
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expressed, the cells became susceptible. Enterococcus faecalis and P. aeruginosa trap 
and degrade AMPs by forcibly releasing dermatan sulfate from epithelial cells
129
.  By 
exploiting deocorin and other protoeoplycans from the surfaces of host cells, dermatan is 
released, which binds to many AMPs and renders AMPs inactive
127
.       
 A prominent method by which cells have developed resistance to antibiotic 
treatments is by effectively pumping out the toxic compounds.  Using an ATP driven 
pump, toxic compounds are released from the host cell
130
.  An example of this system is 
the mexCD-oprJ pump that is expressed in P. aeruginosa
131
.  Although known to work 
against antibiotics
131
, it may also be used against host definsins
127
.     
 Finally, bacterial resistance may be mitigated by suppressing pathways by which 
AMPs are expressed altogether.  For example, cathelicidin is found in high 
concentrations in both mice and humans when infiltrated with Group A Streptococcus
132
.  
β-definsin is another mechanism produced by cells to fight off infection that is induced 
by contact with lipteichoic acid, which is derived from the cell wall
133, 134
.   
In order to stay healthy, the host needs cells that can freely express these 
components, however, in the case of cystic fibrosis; P. aeruginosa inhibits β-definsin and 
cathelicidin.  Using a matrix-assisted laser desorption ionization time-of-flight 
spectrometer, it was found that human β-defensins 2 and 3 were broken down by cysteine 
proteases cathepsins B, L, and S
135
. The results of Taggert et al. suggest P. aeruginosa 
manages to persist in the lungs by expressing the inhibitor cathepsin.     
2.3.2 AMPs Mode of Action against Bacteria 
 Certain AMPs, such as LL37, may not actively seek and destroy infectious agents, 
but rather act as an alarm when the epidermis is punctured.  LL37 expression by 
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epithelial cells causes plasmacytoid dendritic cells to accumulate in a location of 
injury
136
.  LL37 is only found in areas of injury, but accumulations of LL37 are also 
linked to causing skin lesions and rheumatoid arthritis
137
.  Paulsen et al. acknowledges 
that LL37 works synonymously with plasmacytoid dendritic cells, but no evidence exists 
that LL37 lyses the cells
137
.   
 Even though peptides are naturally produced with seemingly endless numbers yet 
to be discovered, a significant step towards wide scale commercialization is to increase 
potency and ensure that they will not interfere with mammalian cells.  Tew et al. have 
taken the approach of synthesizing polymeric phenylene ethynylene that mimics many of 
the features found in AMPs including being cationic and amphiphilic
138
.  A CellTiter 96 
well plate measured the reduction of tetrazolium dyes to formazan by dehydrogenase 
enzymes found in metabolically active cells and was read at 490 nm in a microplate 
reader.  It was found that even S. aureus was  resistant to ciprofloxacin, but was 
susceptible to norloxacin
138
.  These results are very encouraging, but Tew et al. also went 
further by testing for cytotoxicity against mammalian 3T3 and HepG2 cells.  The 
researchers were able to conclude that there was a significantly greater amount of 
prokaryotic cells killed compared to mammalian cells, which is important if the goal is to 
use these chemicals as a replacement for antibiotics.      
 Scientists have been unable to determine the exact mechanism that AMPs use to 
kill bacteria, and are debating whether each peptide uses a different mechanism.  Since 
there is evidence that bacteria interact with peptides very differently, it is plausible to 
consider multiple models that can explain how bacteria are killed by host peptides. 
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 Regardless of the proposed model, the peptide must find a binding spot to the 
bacterium.  This can be accomplished by peptides in monomer or polymer-form either 
attaching to the polysaccharide core or lipid A.  Once a certain concentration threshold is 
reached, the peptide is then able to penetrate the cell membrane
139
.  
 Two models have been proposed that explain how AMPs kill bacteria.  One is 
called the barrel-stave model and the other is called the carpet model
26
.  Both models are 
yet to be verified since the mechanisms leading to cellular death have yet to be unraveled 
(Figures 2.3 and 2.4).   
 Peptides will operate differently depending if the bacterium is Gram-positive or 
Gram-negative
140
.  Gram-positive bacteria have a thicker peptidoglycan layer than do 
Gram-negative bacteria.  However, Gram-negative bacteria possess an inner cytoplasmic 
membrane.   Therefore, in order to disrupt the bacterial membrane of a Gram-negative 
bacterium the peptide requires the specifically-targeting barrel stave approach by the 
AMP, while the Gram-positive bacterium can be compromised by a non-specific 
approach employed by the carpet model
140, 141
.   
 While the literature has focused largely on how AMPs lyse bacteria, ongoing 
research has demonstrated that CP1 can be used to replace antibodies in biosensors 
against pathogenic E. coli.  For example, CP1 binds 10-fold better to E. coli O157:H7 
relative to a Cy5 labeled anti-E. coli O157:H7 antibody
4
.  Gregory and Mello suggested 
that the O-antigen or the flagella antigen may be targets for AMPs since HB101 does not 
bind as well to CP1 when compared to O157:H7
142
.  CP1 is an excellent candidate for 
biosensor material, and performs better than other available AMPs such as pleurocidin, 
cecropin A, and cera totoxin A
143
. 
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Figure 2.3 Barrel Stave model.  A. Peptides approach the cell surface in the alpha-helical 
formation.  B. Peptide monomers undergo reorientation as the cellular phospholipids of 
Lipid A face the peptide hydrophobic groups.  C. The bacterial membrane is then 
ruptured and the pore size may increase depending on the quantity of AMPs.  The AMPs 
will specifically disrupt inner cellular functions that will lead to cell death.    
 
 
 
 
Figure 2.4 Carpet Model.  A. Peptides covalently attach to phospholipid groups onto the 
cell surface.   B. Peptides reorientate so that the hydrophilic groups face the Lipid A 
region. C. Hydrophobic domains of the peptide then face the lipid, causing membrane 
distributions once a certain peptide threshold is reached.  D.  The peptides carve out 
sections of the bacterial membrane, which leads to cytoplasmic leakage and death.   
A B C 
A B 
D C 
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2.4: The Atomic Force Microscope 
2.4.1 Principles of AFM 
   The 1986 Nobel Prize in Physics was awarded to three scientists; Dr. Gerd Binnig 
and Dr. Heinrich Rohrer.  Binnig and Rohrer were awarded the prize for their work on 
the scanning tunneling microscope (STM)
144
.  The STM relies on a very sharp, 
conductive tip that scans along a sample that is, likewise, highly conductive. The 
Scanning Electron Microscope (SEM), which depends on the same principle of 
conductivity, coats a sample with gold nano-particles to make it conductive and the 
current is interpreted into topographical data instead of scanning a sample like a record 
player
145, 146
.  
  The STM belongs to a class of microscope known as the Scanning Probe 
Microscope (SPM).  The STM differs from Scanning Near-field Optical Microscopes 
(SNOMs) by „feeling‟ instead of „seeing‟.  Unfortunately, researchers had to be very 
selective regarding the samples that were studied using SPMs in the 1980‟s.  Samples 
needed to be resistant to alterations that could occur during a scan, and that limited the 
SPMs‟ uses to metallic surfaces.  Further applications of the SPM would have been 
extremely limited without innovation.  In 1986, Binnig and Rohrer reported the invention 
of the atomic force microscope
144
, which would prove far more versatile than prior 
SPMs.  
  The AFM operates by scanning a sharp probe that is typically less than 50 
nanometers in diameter over a surface to obtain 2-dimensional data.  The probe is capable 
of moving nanometers by adjusting the voltage through a piezo.  A laser reflects off the 
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AFM probe and hits photodiode, where voltage is converted to cantilever deflection and 
converted to force
147
.  A change in a laser‟s deflection due to alterations on the sample‟s 
surface enables height data to be recorded.  By shifting the probe‟s position by 
nanometers along the „y-x‟ axes with a sensitive piezo, a combination of the line profiles 
yields 3-dimensional data.  The AFM tip is at least 100 times smaller than a bacterium, 
making it possible to obtain detailed information of microbial surfaces and their 
biomolecules.  In imaging, the AFM is capable of capturing magnifications between 100-
100,000,000 times
148
.  Some ultra-sharp probes are even capable of imaging DNA
149-151
.  
The „x-y‟range by which the AFM can scan is typically 100 micrometers to 0.3 nm.  The 
versatility of the AFM provides superior options for scanning that appeal to researchers 
in numerous disciplines.  
  For decades microbiology has been completely reliant upon tools such as electron 
microscopy, contact angles, epifluorescent microscopy, and X-ray photoelectron 
spectroscopy
152
.  These methods are, for the most part, destructive to bacteria, and cannot 
be used on living cells.  In addition, many of these methods look at cells in a macroscopic 
fashion, often blending hundreds or thousands without garnering data of individual 
cellular variations.  The electron microscope is capable of viewing individual cells 
following gold sputtering of the sample, which kills the cell
153, 154
.  The AFM offers a 
unique perspective at the micro-scale by focusing in on single cells as part of a study.   
 The AFM has two primary functions that include image mode and force mode.  
Image mode can operate via a tapping mode, which oscillates a probe on top of a surface 
or in contact mode that bends the probe as it is dragged along a surface
144, 155
.  Tapping 
mode works by the AFM‟s piezoelectric motor generating vibrations at the resonance 
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frequency of the tip to induce maximum oscillation.  Tapping mode is the most popular 
among biological researchers since it deforms samples the least
156
. The imaging of a 
sample can be accomplished under liquid or air depending on the sample. 
 Force mode operates by fluctuating the AFM probe in the Z direction.  The AFM 
measures force between the probe and sample in a force-versus-distance plot to generate 
force curves
157
.  Figure 2.5 is a representation of a typical force curve.   
X-axis
Y
-a
x
is
Approach
Retraction 
 
Figure 2.5 Representation of a Force Curve While Probing Bacterial LPS   
 
The force cycle is composed of two curves; one being the approach curve in blue, and the 
retraction curve depicted in red.  For much of the approach curve, the forces acting on the 
probe are negligible, which is called the zero interaction region, followed by the probe 
encountering repulsive forces.  These repulsive forces are a combination of van der 
Waals electrostatic forces, solvation, hydration, and steric/bridging forces
157
.   When 
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retracting from touching an object, there tends to be an adhesive pull-off force required to 
break the linkage between two objects. This demonstrates the binding strength between 
tip-sample, since we can measure the pull-off force.     
  The correlation of force data should be conducted under aqueous conditions due 
to inherent capillary forces.  In air, a layer of water will cover both the sample and the 
probe, which forms a meniscus causing an attractive force of 10-100 nN
152
.  This makes 
operating under water much more common for microbiologists and is required for 
meaningful force curves
152
.   
  In force mode, when the cantilever contacts the sample of interest, the cantilever 
compresses, and elongates when being held to the surface during retraction
144
.  The 
motion of the cantilever is comparable to the motion of a spring, which makes force 
measurements significantly more precise.  The spring constant, kz, is a measurement of 
the force required to deflect the cantilever a given distance
158
 
  
   
 
Here, N is force in Newtons, m is distance in meters, and kz is the spring constant. 
  Using Hooke‟s law, Equation 2, the forces encountered during the force cycle can 
be determined with
158
 
 
   
While manufacturers often provide an estimate of the cantilever spring constants, 
multiple researchers have noted that the spring constants of their cantilevers do not fall 
within the manufacturer‟s specifications159.  Hence, each researcher should determine the 
spring constant using one of the available methods.  Advantages of using the thermal 
(1) 
(2) 
. 
. 
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method are ease of use, independence of material, and geometry comprising the 
cantilever.   
2.4.2 AFM Method for Studying Bacterial Interactions  
 The AFM is an innovative tool compared to existing microscopy methods in that 
samples require minimal preparation and high resolution images can be achieved with 
little sample deformation.  Force mode is a tool unique to the AFM and enables 
measurement of molecular-molecular interactions between the AFM probe and LPS.  
AFM force profiles have been used extensively in numerous microbiological studies such 
as analyzing effects of cranberries on E. coli pili and Pseudomonas aeruginosa LPS 
binding to silicon.    
 Liu et al. used both approach and retraction data to analyze cranberry effects on 
pathogenic E. coli and E. coli HB101 that would not be considered capable of causing 
urinary tract infections
160
.  Using steric modeling software, pili lengths were found to 
decrease significantly under cranberry treatment from 150 nm to 50 nm.  Additionally, 
pull-off forces definitively showed that for the pDC1 strain, 80% of the attractive forces 
were >0.5 nN, whereas higher concentrates of cranberry juice resulted in only 40% of the 
retraction forces being >0.5 nN
160
.   
The AFM is capable of interacting with structures nanometers in length, which 
makes it ideal for studying bacterial O-antigens.  Mechanically probing the O-antigens 
elucidates unique properties that would otherwise for unnoticed with other microscopy or 
chemical analyses. Atabek et al. also carried out novel research primarily with the AFM 
by comparing P. aeruginosa PAO1, which expresses the A-band and B-band O-antigen, 
with AK1401 that expresses only the A-band antigen
161
.  By analyzing the retraction 
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forces and pull-off distances, PAO1 was found to have longer O-antigens and was the 
only strain to have attractive forces of >1.2 nN
161
.   
2.5: Quartz Crystal Microbalance with Dissipation 
Monitoring 
 
 The QCM was an innovative tool that measures small deposits of mass onto a 
quartz crystal.  The QCM is sensitive enough to measure 10
-11
 g-cm
-2
, which is 
significantly more sensitive than conventional scales.  The QCM takes advantage of 
minute changes in resonant frequency due to adsorbed mass.  Other advantages of the 
QCM are realtime monitoring of adsorption and custom coatings of quartz crystals.  
Although the QCM was capable of tasks unique to this instrument, the limitation of the 
„missing mass effect‟ due to viscoelastic properties of some samples was problematic162.  
The Sauerbrey equation, which was the primary method for data evaluation, correlated 
frequency changes to changes in mass.  Consequently by neglecting viscoelastic effects 
that dampen quartz crystal oscillations, the Sauerbrey equation would underestimate 
adsorbed mass.  Quartz crystal usage was therefore limited to systems with rigid deposits 
until dissipative effects could be accounted for.    
2.5.1 Principles of QCM-D 
In the past decade the quartz crystal microbalance has evolved with the addition 
of dissipation-monitoring, which has made this technique more useful in life sciences 
research.  Similar to how the AFM made it possible for SPMs to study biological 
samples, the QCM-D has made it possible for highly viscous samples such as whole cells, 
viruses, peptides, etc. to be studied.  Being a recent innovation, researchers are still 
developing modeling components to calculate thickness, shear stress, and viscosity.  
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Nevertheless, the QCM-D is significantly more powerful than its predecessor, the QCM, 
because it accounts for dissipative affects that make thickness and adsorbed mass 
calculations significantly more accurate. 
In 1959, Sauerbrey derived an equation relating the frequency shift, ∆f, of an AT-
cut oscillating piezoelectric crystal induced by added mass.  Now known as the Sauerbrey 
equation, QCM makes use of
163
 
 
where A is the quartz crystal active area, μq  is the shear modulus for an AT-cut quartz 
crystal (
scm
g
2
11 10947.2 ),  ρq is the quartz crystal density ( 3 648.2 cm
g
), ∆m is the 
change in mass per unit area, and fN is the fundamental resonant frequency of the crystal 
at N overtone.  The crystal will resonate when the quartz thickness is at odd integers of 
half wavelengths of the induced waves
164
.  Hence, the user will operate the crystal at the 
1
st
, 3
rd
, 5
th
, etc. overtone numbers, which affects the resonant frequency as  
0
2
nf
t
v
nf
q
q
 
where n is the overtone number, υq is the velocity of found through the quartz, and tq is 
the thickness of the quartz.   
 In order to validate the results of the Sauerbrey equation, the areal mass must be 
assumed to be evenly distributed throughout the crystal.  Equation 5 can then be used to 
express either a thickness or density on the crystal 
23 m
kg
m
kgm
tm
A
M
qqq
 , 
, 
, (3) 
(4) 
(5) 
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where M is the added mass, and A is the active area.  In addition to being evenly 
dispersed, the added mass must also be small relative to the crystal and be rigid so that 
there is no deformation induced by the oscillations.   
 Traditional QCM is only valid in gaseous conditions.  This was the case until 
1995 when an innovation accounted for dissipation effects
165
, giving rise to the QCM-D.  
Rigid deposits will resonate with the crystal and the energy lost per oscillation will be 
significantly less than if the deposit is highly viscoelastic.  Viscoelastic films, for 
example, will absorb more energy per oscillation. This loss of energy is not accounted for 
in the Sauerbrey Equation
163, 165, 166
.  Briefly, dissipation (D) is defined as 
stored
lost
E
E
D
2
 
where Elost is the energy lost per oscillation and Estored is the energy that remains 
following an oscillation.    
 Life science research is often conducted in a liquid environment to retain cells in 
their natural state and conserve viability.  Cellular adhesion to quartz crystals can be 
monitored, along with viscoelastic properties with a dissipative factor that accounts for 
liquid environments 
 
Here ∆ρ is the density change of the bulk liquid and ∆η is the viscosity change of the bulk 
liquid.  Equation 8 corrects for bulk liquid viscosity and density changes that are also 
monitored with crystal frequency changes
167, 168
,   
 
, 
. 
. 
(6) 
(7) 
(8) 
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Indeed, incorporating dissipative effects is important for correcting “loss of mass” that 
acoustic sensors encounter under non-idealistic conditions
162
.  The Sauerbrey relation 
clearly is an over simplification, which can be used in Equation 8 for calculating a mass, 
but significantly deviates from the true mass
162
 
 
Here Ms is the Sauerbrey mass, M is the true mass, 1 refers to the thin soft overlayer, 2 
refers to the liquid bulk phase, ρ is the density, η is the shear viscosity coefficient, G’ is 
the storage modulus, and G” is the loss modulus.    
Undergoing further simplification, Equation 9 may be reduced to
162
 
Ms = M (1-α) 
where α is a modification neglected by the Sauerbrey relation due to mechanical 
properties of the overlayer material and aqueous solution, M is the true mass, and Ms is 
the Sauerbrey mass.  By making dissipation monitoring possible, QCM-D becomes much 
more useful to life science research. 
 Voigt Viscoelastic modeling includes terms such as bulk liquid viscosity and 
density that allows for precise film thickness and areal mass calculations.  From QCM-D 
raw data, the deposited layer thickness can be calculated using Voigt viscoelastic 
modeling for a film in liquid
169, 170
 
            (11) 
           (12) 
         (13) 
 
, 
. 
(9) 
(10) 
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       (14) 
                  (15)  
                        (16)  
Here dq is the quartz thickness, ρ1 is bulk liquid density, η1 is bulk liquid viscosity, η is 
shear viscosity of adsorbed layer, μ is shear modulus, and d is film thickness.       
2.5.2 Applications of QCM-D 
 The realm of research involving quartz crystal technology has expanded to 
development of self-assembled monolayers (SAMs), deposition and orientation of cells 
and proteins, and polymer construction.  While useful for fundamental research, the 
QCM-D is also being used as a novel biosensor for detection of biological agents such as 
bacteria, fungi, and viruses.   
2.5.2.1 QCM-D and Polymer Development 
 A novel use for the QCM-D is to create „smart‟ surfaces that have undergone 
dramatic changes that alter their wettability
171
 or respond to temperature, light, and 
pressure
172, 173
.   Such desire for new material has led several groups to study thin films 
on gold surfaces.  Using the QCM-D in association with X-ray photoelectron 
spectroscopy and contact angles, Park et al. demonstrated the thermoresponsive 
properties of polymers in temperature ranges from 25°C to 60°C
171
.  By monitoring 
dissipation at the seventh harmonic, the polymer absorbed 3 times of the amount of 
energy per oscillation per 3°C increase.   
 Dissipative effects of adsorbed samples are amplified by what is termed the 
swelling effect
174-177
.  Swelling of a sample occurs in a liquid environment where 
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polymers accumulate water.  Such effects can be monitored with dissipation monitoring.  
A study following up on swelling effects explored this phenomena by comparing the 
adsorption of ethyl(hydroxyethyl) cellulose (EHEC) and a modified EHEC on 
hydrophobic gold domains
175
.  Surprisingly, the hydrophically modified EHEC retained 
significantly more water, as was determined through the dissipation monitoring.  The 
viscoelastic modeling indicated a thickness of 2.6 nm and 10.0 nm for the hydrophilic 
and hydrophobic adsorbents, respectively, indicating the hydrophilic polymers were 
densely packed.  A large degree of contact between polymers on the hydrophilic surface 
likely did not favor the trapping of water, while the hydrophobic EHEC was more 
distributed and entrapped water molecules
175
.   
2.5.2.2 QCM-D and Protein Development 
 The QCM-D can be vital for understanding protein behavior, such as for 
preventing bacterial aggregation on protein-coated implanted catheters.  Bovine 
submaxillary gland mucin (BSM) and bovine serum albumin (BSA) are model proteins 
commonly used to mimic in vivo conditions
178
.  The QCM-D used to show that BSA 
adsorbs in a rigid layer and can prevent the adsorption of BSM
178
.   
 Protein swelling leads to conformational changes that expose different functional 
groups for cell-cell interactions.  Fibrinogen was found to absorb more water when 
adhered to titanium oxide when compared to gold and tantalum substrates.  This 
conclusion was reached by monitoring the dissipation of fibrinogen films adsorbed to 
metallic substrates.  The authors were unable to explain the mechanisms for differences 
in protein uptake of water, but the study demonstrated that different surface materials can 
lead to significant changes in protein orientation during adsorbtion
179
.        
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2.5.2.3 DNA Biosensor Development 
 One of the newest proposed applications of the QCM-D is to use the device as a 
biosensor.  Biosensors can use any single or combination of methods that include optics, 
microbalances, electrochemistry, and temperature
180
.   For instance, the QCM-D real-time 
monitor  assembly of DNA
181
.  In a recent study, two 45-case DNA monomers consisting 
of two 20-base sequences, which were separated by a 5-base DNA sequence, were 
reintroduced to the quartz crystal in 10 successive steps
182
.  Between steps, HEPES was 
used to remove non-specifically adhered DNA monomers. Lazeerges et al. demonstrated 
that with each successive step, the frequency change monitored decreased from ∆f1=-166 
Hz to ∆f10=-52 Hz.  This pattern can be attributed to steric hindrance between DNA 
strands and to increased thickness of the DNA layer that induced energy losses, which is 
due to increasing viscosity
182
.   
 The DNA biosensors took advantage of di-sulfide bonding to construct repeating 
polymer chains.  Carmon et al. used the same principle to immobilize estrogen onto gold-
quartz crystals and test for the adherence of xenoestrogens
183
.  The C-terminal hormone-
binding domain was considered the control, which has demonstrated a strong affinity to 
estrogen
184
.   The study demonstrated that testosterone and progesterone had no binding 
ability to estrogen, but estroil binds well to estrogen.  Therefore, chemicals such as estriol 
are important for treating atrophic vaginitis
185
.  
2.5.2.4 Mammalian Cell Studies 
 QCM-D has been used to help design substrates that resist cellular adhesion.  
Applications for such a biosensor vary from preventing catheter related bloodstream 
infections to improving wound healing.  Andersson et al. proposed using a supported 
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phospholipid bilayer (SPB) with QCM-D and fluorescent microscopy techniques and 
found a nearly total reduction of rat pancreatoma cellular adhesion
186
.  The observed 
reduction was attributed to phosphorylcholine groups that have been found to also reduce 
protein
187-189
 and platelet adsorption
190
 to polymers and metals.  
In one study, epithelial cells were grown on quartz crystals and monitored by 
measuring frequency (Hz) and resistance (Ω)191.  Once an established extracellular matrix 
was constructed, as was verified using fluorescence light microscopy, cells were treated 
with nocodazole.  Nocodazole, a microtubule binding drug, is important for 
understanding signaling pathways for cancerous cells
192-194
.  Marx et al. monitored the 
deposition of nocodazole onto the epithelial cells and found frequency signaling drops of 
360 Hz and a small increase in resistance of 14 Ω191.  They associated the changes to both 
nocodazole adhesion to the cells, as well as cellular rounding and spreading on the 
surface that was induced by the nocodazole.   
 Marx et al. further studied epithelial cell responses to ethylene glycol bis(2-
aminoethyl ether)-N,N -tetraacetic acid (EGTA)
195
.  After 2 hours of exposure on the 
quartz crystal, fluoresce ence microscopy confirmed that the epithelial cells were entirely 
removed.  A surprising finding was that the resistance after shifting to 0 (indicating no 
cells were present), rose by 50 Ω before subsequent EDTA treatments.  This is indicative 
of the remaining cells becoming more rigid and attempting to further anchor to the 
substrate
195
.   
2.5.2.5 Bacterial Biosensor 
 The QCM-D has been well documented for its potential as a biosensor, but 
recently the intention of using it for detecting pathogenic bacteria has been suggested
34
.   
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The piezoelectric biosensor has been commonly proposed to operate by depositing an 
underlying layer of antibodies that would selectively bind to pathogenic bacteria
196-199
.  
Other methods that used antibodies first masked the gold layer with SAMs that 
immobilize E. coli O157:H7 with hydrazide linkers.  Once the bacteria were firmly 
attached to the SAMs, antibodies were introduced to specifically target E. coli 
O157:H7and a change in mass resulting from antibody adhesion to bacteria yielded that 
the antibodies targeted E. coli O157:H7
200
.   
2.5.2.6 Preventing Bacterial Adhesion 
The QCM-D has also been used to monitor the effectiveness of materials and 
conditions that can prevent bacterial adhesion.  For example, ionic strength and 
hydrophobicity were found to effect adhesion of the fimbriated (MS7fim+) to gold quartz 
crystal, whereas the nonfimbriated (MS7fim-) E. coli was not impacted
201
.  Otto et al. 
found both sets of bacteria to preferentially adhere to the hydrophobic substrate (methyl-
terminated gold) compared to the hydrophilic gold.  In addition, the nonfimbriated strain 
adhered better in every ionic strength solution and surface condition.  Although 
unexpected, the authors attributed these results to shielding effects of the cellular surface 
charges and dipole interactions at higher ionic strengths.  The fimbriae may also be 
affected due to the presence of ionic groups leading to additional surface charge
201
.           
2.5.2.7 Disrupting Biofilms 
 For applications with medical devices, prevention of bacterial adhesion is widely 
deemed as the most viable option for combating bacterial infection, Reipa et al.  used the 
QCM-D in order to monitor biofilm disruption
202
.  Pseudomonas aeruginosa were grown 
on a gold quartz crystal and a bleach solution was applied.  The depletion of the biofilm 
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was monitored in real time.  Bleach is a popular sterilizing agent, but is not safe for in 
vivo.  The search for chemical agents that specifically target biofilms is ongoing, and it is 
important to have a basis for understanding how potent chemicals such as bleach disrupt 
the biofilm.     
2.5.3 Effects of Acoustic Waves on Biological Samples 
 The QCM has also been used extensively to study cellular adhesion and growth 
on quartz crystals; however, the calculated changes in mass are controversial due to the 
viscoelastic nature of cells. Only in the past decade have researchers begun to explore 
whole cell binding with acoustic wave sensors.  Several groups have raised doubts on 
whether the oscillating crystal can break non-specific bonds, receptor-ligand bonds, and 
covalent bonds
203, 204
.  In these studies, virus removal was detected as the drive amplitude 
increased from the nominal value of 1 V to 10 V.  However, Evardsson et al. discovered 
contradicting results when attempting to remove 1-Palmitoyl-2-oleoyl-snglycero-3-
phosphocholine and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanol amine-N from the 
quartz crystal
205
.  Regardless of the voltage used, mass was not removed from the 
substrate.  Frequency and dissipation results were identical for when experiments were 
repeated at drive amplitudes of 0 (50 mV), 5, and 10 V, meaning biological samples 
remain unperturbed by the QCM-D
205
.  Descrepancies between the studies were 
attributed to the use of plano-convex crystals that increase the maximum oscillation 
amplitude, irregular shape of the viruses that increase torque, and antibody-antigen bonds 
were weaker for the case of viral adhesion
205
.        
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2.5.4 AFM/QCM-D Studies 
 To date, many studies have combined QCM techniques with fluorescence 
microscopy and SPR for studying cellular adhesion, but few have incorporated AFM 
imaging and none have compared binding forces with the AFM to QCM-D.  Another 
significant area of study is monitoring  adsorption of self-assembled monolayers that 
have also demonstrated an ability to significantly alter surface characteristics such as 
wettability and surface free energy
178, 206, 207
. Briand et al. immobilized thiolate SAMs 
onto gold substrates and explored the binding of rabbit immunoglobulin G (rIgG)
208
.  
AFM tapping mode™ was used for topographical imaging for roughness analysis.  The 
AFM was employed in part to validate QCM-D for the system of interest since a 
homogenous substrate is necessary for viscoelastic modeling.  Since the AFM is unable 
to analyze beyond the topography, the rigidity of the immunoglobulin on the SAMs was 
also investigated.  In another AFM-QCM study, the deposition of platinum on gold 
electrodes was monitored in real time with the QCM, while roughness was observed with 
the AFM
209
.   
 While rare, a few studies have made efforts to combine the techniques of AFM 
and QCM for studying whole cells.  Using a polyurethane-coated quartz crystal, attached 
S. bayanus, L. oenus, and E. coli following S. cerevisiae imprinting (residues of yeast left 
behind following rinsing) were imaged
210, 211
.  Tapping mode AFM was capable of 
capturing images of S. cerevisiae imprinting to verify residuals remained. The dual-
AFM/QCM technique was capable of determining the adhesion strengths of yeast cells 
and proved the combination could be used as an effective biosensor.       
 
 
Section 2                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
37 
 In a study by de Kerchove and Elimelech, adsorbtion of alginate to silica quartz 
crystals were monitored with the QCM-D and further analyzed under AFM force 
mode
212
.   P. aeruginosa produces alginates in the extracellular polymeric substances 
(EPS) to form biofilm matrices
213, 214
.   Alginates are produced by the mucoid strain P. 
aeruginosa SG81, which concentrates calcium ions in the biofilm
213
.  The goal of de 
Kerchove and Elimelech was to evaluate over a range of ionic strength solution (0- 300 
mM) how dissolved calcium alters the alginate layer.  Using the QCM-D, areal mass, 
thickness, and viscoelastic properties of the adsorbed alginate were determined from real 
time adsorption data, while the AFM was useful for determining adhesion forces and 
pull-off distance of the adsorbed alginate.  The pull-off distance increased as ionic 
strength of the alginate layer also increased from 0-100 mM, while Fadh decreased over 
the same range of ionic strength.  The QCM-D results demonstrate the adsorbed alginates 
form more rigid layers as the dissipation decreased with correlation to increased ionic 
strength.  Decreases in adsorbed water in alginates has been found to be due to reduction 
of hydrogen bonds
215
.  The larger distances obtained with AFM at higher ionic strength in 
the presence of calcium suggest that the presence of higher concentrations of monovalent 
ions induces the alginate complexes to be less efficiently bound together.  The study 
demonstrated electrostatic interactions resulting from ionic strength solution changes 
impact the alginate layer and may lead to treatments against P. aeruginosa infection.   
2.6: Interfacial Free Energy 
Thermodynamics may be employed to understand the microscopic forces that 
promote bacterial attachment to substrates. To understand the thermodynamics of 
bacterial adhesion, some assumptions need to be made.  Bacterial adhesion is considered 
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favorable if the change is negative upon creation of the bacteria-surface interface
216
.  
Likewise, adhesion is not considered favorable if surface free energy increases.  
Neglecting electric and biochemical interactions, the change in surface free energy for a 
given bacterium may be expressed as
216
 
 
where F
adh
 is the free energy of adhesion, BS is the bacterium-substratum interfacial 
tension, BW is the bacterium-liquid interfacial tension, and SW is the substratum-liquid 
interfacial tension.  Young‟s Equation expands on the above free energy balance and can 
be used to obtain data on interfacial tensions of solid surfaces with the relation
217
 
 
where SB is the interfacial tension between a solid substratum and bacterium, SW 
between the solid substratum and liquid, WB between the liquid and bacterium, and  is 
the contact angle of the liquid resting on the solid.  Since SW is a function of both SB and 
WB, using experimentally derived contact angle data and surface free energy data and 
combining with Young‟s Equation, the relationship yields216 
 
The purpose of thermodynamic studies is to determine how bacterial adhesion varies 
when different types of substrates are each considered.  BV relates to the tension of the 
liquid medium ( lv) in three ways
218
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 In the case of Equation 20, F
adh
 decreases, and we would expect an increase in 
the number of bacteria adhering to a substrate.  In Equation 21, the opposite would be 
true.  This scenario would represent a decrease in the number of adhering bacteria.  In the 
case of Equation 22, bacterial adhesion is independent of surface tension
216
. 
 One method for calculating a substrate‟s surface free energy is to measure contact 
angles with water, water n-propanol mixtures, or -bromonaphthalene, which vary in 
terms of polarity.  A more common set of liquids that can be used to measure contact 
angles to calculate the surface free energy includes water, formamide, and 
diiodomethane.  Surface free energy can be calculated with the following
219
 
 
where d is the dispersion component, p is the polar component, γS is the surface free 
energy of the solid, γW is the surface free energy of the liquid, and πe represents the 
spreading pressure.  Equation 23 generates a least squares regression analysis useful for 
multiple measured angles to obtain the surface free energy
219
. 
   Surface tensions can be calculated via the Young-Dupré Equation
178, 220
 
 
where 
- 
and 
+
 are the electron donor and electron acceptor parameters, B is bacterium, L 
is liquid and 
 
is the surface tension of the probe in the liquid
220
.   
To calculate the total interaction energy between the bacterium and substrata in 
water ( Gadh
Total ), the forces between dipole-dipole, dipole-induced dipole, and induced 
. 
, 
, 
(22) 
(23) 
(24) 
 (25) 
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dipole LW long-range interactions are expressed in a single term, and the acid-base short 
range force characteristics are presented as a separate term yielding
220
 
Gadh
Total Gadh
LW Gadh
AB  
where 
 
and 
Gadh
AB 2( W ( B S W ) W ( B S W ) B S B S )  
 Another method for determining ( Gadh
Total ) can be to measure the free energy 
between bacteria [1], substratum [2], and the medium in with which the substratum is 
immersed in [3], and 3, which is the surface tension of the water that is expressed as 
G1,2,3.  The sum of the interactions is
221
 
G1,2,3 G1,2 G1,3 G2,3 2 3 
To calculate the free energy between bacterium, substratum, and immersion liquid, Gij, 
where i and j represent [1], [2], or [3], the following equation can be used
221
 
Gij ij i j 2( i
LW
j
LW
i j i j ) 
 In a study comparing 5 strains of bacteria, a thermodynamic model predicted the 
attachment of bacteria to substrates including sulfonated polystyrene, acetal resin, 
polyethylene, polystyrene, and fluorinated ethylene-propylene copolymer during the 
initial stages of experimentation
216
.  An unexpected result occurred during the experiment 
when bacteria were retained to the substrates, despite F
adh
>0.  Absolom et al. suggested 
that this phenomenon may have been due to electrostatic interactions between the 
, 
, 
. 
. 
. 
(26) 
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(28) 
(29) 
(30) 
 
 
Section 2                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
41 
substrate and bacteria.  When the ionic strength of the liquid was very low, bacterial 
adhesion was virtually non-existent due to increased electrostatic repulsion
216, 222
.  
 Postollec et al. explored the coaggregation of Streptococcus sanguis and 
Actinomyces naeslundii, which are found in the human oral cavity.  By collecting 
thermodynamic data on the bacteria using contact angles, they found that the bacteria 
have a high affinity towards each other since heat is released during binding.  Hence, 
bacterial coaggregation was found to be enthalpy driven
223
.     
 While the thermodynamic model is preferable for some researchers of bacterial 
surface retention, DLVO theory is an alternative method, which will be developed in the 
next two sections.   
2.7: Guoy-Chapman Model of Electrostatic Interactions 
 The Gouy-Chapman theory suggests a correlation between the charge density and 
electrical potential of a substrate to the concentration of ions in a surrounding solution
224
.  
This is especially important in measuring ions in solution that may impact the viability or 
adhesion of bacteria.  According to the Nernst Equation, activity of a solution may be 
measured in equilibrium partitioning between two phases (0 and )
225, 226
 
10 exp( ZFE0 /RT) C exp( ZiFE0 /RT) 
where  is the chemical activity of the ion, C is the ion concentration, E is the electric 
potential,  is the activity coefficient of the ion, Z is the charge on the ion, E is the 
electrical potential difference between phases 0 and , R is the gas constant, T is 
temperature, and F is the Faraday constant
225, 226
.  
 If the concentration of ions can be computed in phase 0, then the activity 
coefficient may also be determined
226
 
, (31) 
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Ci0 (Ci / i0)exp( ZiFE0 /RT) 
where the variables correspond to phase . 
 The Gouy-Chapman theory was established to form a relationship between 
solutions and charged surfaces and is expressed in the Grahame Equation
226
 
2 (0.00345) Ci (exp( ZiE0 /25.7) 1)
i
 
where  is the density of charged particles, Eo is the electrical potential, and Ci  is the ion 
concentration at infinite distance from the substrate
226
.   
 The Poisson-Boltzmann Equation yields the potential, electric field, and 
counterion density at any point between two substrates.  The Poisson-Boltzmann 
Equation is expressed as
226
 
d2 /dx 2 ze / 0 (ze 0 / 0)e
xe / kT  
where  is the potential,  is the number density of ions of valency z, k is the 
Boltzmann‟s constant, T is temperature, 0 is the permittivity of free space, and e is 
electronic charge.    
 Substituting the Grahame Equation into the Poisson-Boltzmann Equation yields
226
 
d3Ex /(dx
2) 1/( 1 0) Z iFCi exp( Z iFE0 /RT)
i
 
This equation is useful for calculating the electric potential of a solution and the external 
concentrations when  is a low value
224
.   
 Stern made a modification to the Gouy-Chapman theory by taking into account 
changes in α due to ion binding onto the substrate surface.  This relationship between 
surface ligand Q” and an ion S’ is expressed in the following form225 
[QSX Y ] KQS[Q"][S']0  
, 
. 
, 
, 
, 
(32) 
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where Q” and [QSx+y] are ion concentrations, S’0 is the ion concentration at the surface, 
KQS is an association constant, and x and  y are charges
225
.  
Gouy and Chapman combined both the Poisson Equation, which describes the 
attraction of counterions to a surface, and the Boltzmann relation, which describes the 
repulsion of counterions in an area of high concentration.  In the case with low surface 
potential, (0), the following statement can be made
225
 
(0) /( a 0 ) 
where a is the dielectric constant, 0 is the permittivity of free space,  is the surface 
charge density, and  is the inverse Debye length ( [( 0 akT) /(2z
2e2c)]0.5). Across a 
distance, x, the potential varies as
225
      
(x) (0)exp( x) 
 The surface potential, (0), is predicted by the Gouy Equation and is directly 
related to the concentration of ions in solution, c, and the surface charge density, , by
225
 
sinh[ze (0) /2kT] A /(c)0 / 5 (8 a 0kT)
0.5 /(c)0.5 
When the potential is larger than 25 mV, Gouy-Chapman theory predicts the rate at 
which the potential drops increases near the substrate as
225
 
(x)
(2kT)
e
ln(
exp[
e (0)
2kT
] 1
exp[
e (0)
2kT
] 1
)ln
[1 exp( x)]
[1 exp( x)]
 
By having an understanding of the mechanisms that lead to colloidal interactions, it is 
possible to predict what certain substrate modifications will have on bacterial retention.   
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2.8: DLVO Theory 
DLVO theory, developed by Derjaguin, Landau, Verwey, and Overbeek, provides 
a quantitative framework to calculate molecular interaction profiles, by summing 
electrostatic and van der Waals interactions
227
. Electrostatic forces arise from double-
layer theory.  When an object is placed into an electrolyte solution, its surface becomes 
charged.  If the object, for example, contacts oxygen molecules on the surface, then 
hydrogen atoms in the water will be attracted to the charged molecules
228
.  Usually a 
small amount of the oxygen molecules will interact with the hydrogen molecules, leaving 
a net negative charge on the substrate.  The net negative charge attracts positively-
charged ions in the solution that would normally have been dissociated.  Double-layer 
theory can be applied to bacterial adhesion by correlating electrostatic potential produced 
by charges to the ion density in a bacterium‟s cytoplasm228. 
London dispersion forces undergo polarization of molecules into dipoles
228
.  
Originally, van der Waals forces were considered the only intermolecular forces, but this 
definition neglected specific interactions forces, solvation forces and depletion forces.  
Between two spheres, the van der Waals interactions may be expressed as
228
 
 
where h is the separation distance, evaluated as H0, the theoretical closest distance 1.57 
Å, A123 is the Hamaker constant, am is the radius of the bacteria, and ap is the radius of the 
tip.   
 The Hamaker constant, A, is equal to  
 
, 
, 
(41) 
(42) 
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where q is the number of molecules per unit volume interaction between two bodies,  
C’=251e2α2, e is the energy, and α is energy of interaction between two atoms with static 
polarisability.   
 The Hamaker constant is valid for vacuum between particles, but for a liquid 
medium, an effective Hamaker constant is used
229
, 
 
Taking the geometric means of each phase, 
 
and for interaction of identical particles, 
 
Figure 2.6 displays the forces as a function of particle separation.   
 
Figure 2.6 DLVO interactions between two spheres.  The blue curve represents van der 
Waals potential (attraction), the green curve represents electrostatic potential (repulsion), 
and the red curve is the net potential. The energy barrier is when the net potential reaches 
a maximum.  As the distance between objects increases, DLVO potential approaches 
zero.  Adapted from
3
.  
 
A modification to the DLVO theory incorporates hydrophobic effects, also known 
as acid-base interactions or electron donor/electron acceptor.  XDLVO and DLVO-AB 
are exactly the same since hydrophilic substrates tend to be more acidic, and hydrophobic 
. 
. 
(43) 
(44) 
(45) 
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substrates have a tendency towards being basic
230
.  In some cases, bacterial retention to a 
substrate is better modeled using the modified XDLVO theory as opposed to the DLVO 
model, but both ignore important factors such as surface roughness and nanoscale 
molecular forces on the substrates
230
.   
 Another modification that has been made is called soft-particle DLVO theory.  
Soft particles are assumed to be polyelectrolyte brushes.  Soft-particle DLVO is pertinent 
to AFM probing of LPS since bacteria have soft membranes.  The expression of soft-
particle theory is
231-233
 
 
 Here, μ is electrophoretic mobility, ε0 is permittivity of vacuum, εr is relative permittivity 
of the medium, η is medium viscosity, and e is elementary charge.  κm is Debye-Hueckel 
parameter of the surface region, ψDON is Donnan potential, and ψ0 is potential at boundary 
between surface regions, which are expressed as, 
 
 
 
where k is the Boltzmann constant, T is temperature, z is valency of bulk ions, and n is 
concentration of bulk ions.  
 Sharma and Rao found that Paenibacillus polymyxa adhesion to pyrite and 
chalcopyrite minerals was better predicted with DLVO theory over the thermodynamic 
method
229
.  Indeed, the thermodynamic method predicted no bacterial adhesion to the 
. 
, 
, 
, (49) 
(48) 
(47) 
(46) 
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minerals would occur, which was experimentally disproven.  The DLVO theory accounts 
for repulsive forces between bacteria and flocculation of minerals, which better predicted 
the experimentally observations of bacterial adhesion.    
 While there has been some success in predicting bacterial adhesion using DLVO 
theory
229, 234-240
, usually bacterial adhesion is governed by forces other than those 
included in the DLVO theory
241-244
.  Treating bacteria as if they are inert particles is the 
limiting factor in this model, and in words of Henri Theil, “models are to be used, not to 
be believed”245.   
2.9: Zeta Potential 
 In order to quantify electrostatic interactions for colloids, we typically measure 
the zeta potential.  A general definition of the zeta potential is the potential at the solid-
liquid interface for any colloid
246
.  The zeta potential measures the colloidal charge at the 
point of the slipping plane.  DLVO theory predicts whether a colloidal system is stable 
with respect to van der Waals attractive and double layer repulsive forces.  For a system 
to be considered stable, the double layer repulsive forces must be greater than the van der 
Waals attractive forces
246
.  
Charges are induced when colloids are immersed in aqueous solution, which 
creates a double layer around each particle or surface.  The charge density is namely 
caused by protonation, deprotonation, and adsorption, and leads to an electric field that 
attracts oppositely charged ions while repulsing co-ions. The charges are dispersed in 
several distinct barriers (Figure 2.7): 
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   Surface charge of the colloid   
      
          
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7 Representation of solvent layers surrounding a colloid. 
 
For an E. coli colloid, since the bacterial surface charge is negatively charged, oppositely 
charged ions will be drawn in; hence the Stern and diffuse layers will be net positively 
charged.     
 Zeta potential analyzers do not directly measure the zeta potentials, but are 
derived through the Smoluchowski approximation
247
 
2
)(2 kafz
U E  
where UE is the electrophoretic mobility (charge on ion/frictional coefficient), ε is the 
dielectric constant, z is the zeta potential (mV), f(ka) is Henry‟s function (assigned the 
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value of 1 for particle sizes <0.2 μm and 1.5 for colloids > 0.2 μm), and η is the viscosity 
(Pa·s).       
 The objective of measuring the bacterial zeta potential is to predict how a 
bacterium, through electrostatic interactions, will behave in a particular environment and 
what agents can alter the bacterial zeta potential.  Atabek and Camesano used zeta 
potentials to verify that chemicals used to bind bacteria to glass did not have adverse side 
effects on a Pseudomonas strain
161
.  They were able to definitely argue that the 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) / N-hydroxysuccinimide 
(NHS) treatment was not altering the bacterial LPS when compared to poly-L-lysine 
(PLL).   
 Emerson and Camesano reported how differing ionic strength solutions altered 
zeta potentials of C. parapsilosis and P. aeruginosa
241
.  In general, higher ionic strength 
MES buffer resulted in the bacteria having a reduced zeta potential.  Changes in zeta 
potentials in lower ionic strength solutions were attributed to soft-particle DLVO theory 
being invalid under these conditions
241
.  
 
 
Section 3                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
50 
3: Methods and Materials 
3.1: Cell Culturing 
 In order to probe the role of LPS properties, a total of 13 E. coli strains were used; 
3 being control strains that lacked the O-antigen with the K12 core-group, and the 
remaining having well defined core types and O-antigens (Table 3.1). 
 
Table 3.1 Strains Used in Present Study 
Green font denotes control strains (No O-antigen). 
    
  Strain  Source 
       
   E. coli HB101 (ATCC 33694)  ATCC1 
   E. coli K12 (ATCC 29425)  Natick Labs2 
   E. coli ML35 (ATCC 43827)   Natick Labs 
       
   E. coli O26:K60:H11 CCUG3  
    E. coli O35:H10 (ATCC 23525) ATCC 
   E. coli O55:H7   ECOR4 
   E. coli O117:K98:H4  CCUG  
   E. coli O113:H4 Health Canada 
   E. coli O113:H21   ECOR 
   E. coli O157:H7 (ATCC 43895)  ATCC 
   E. coli O157:H12 Health Canada 
   E. coli  O157:H16  Health Canada 
   E. coli O172:H- CCUG  
 
     
1
American Type Culture; 
2
US Army Natick Soldier Research, Development and 
Engineering Center; 
3
Culture Collection, University of Göteborg, Sweden.  
4
Escherichia 
coli Reference Collection.   
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Cells were stored long term in 50/50 vol% glycerol-water at -80 C and short term stored 
(<2 weeks) on Luria Broth Agar (LBA) (Sigma-Aldrich, USA) plates. Bacterial colonies 
were streaked from individual colonies and pre-cultured in a 10 ml flask of Luria Broth 
media (LB) (Amresco, USA) for ~14 hours at 37 C.  A 0.5 ml sample of pre-cultured 
bacteria was used to inoculate 50 ml of LB media and cells were cultured at mid-
exponential phase to an absorbance of 0.50, which was determined with a 
spectrophotometer at 600 nm (Thermo Spectronic, USA). Cells were washed 3 times by 
centrifugation for 10 mins with sterile pH 7.4 0.01 M phosphate buffer saline + 0.138 M 
NaCl + 0.0027 KCl (Sigma-Aldrich, USA).      
3.2: Cecropin P1 (CP1) and Cecropin P1 with Cysteine 
Residue at the C-terminus (CP1-cys) 
  
 CP1 (≥95% purity, Sigma-Aldrich) was short-term stored (<3 months) at 4°C as a 
lyophilized powder.  CP1 was reconstituted in ultrapure water (18.2 MΩ cm resistivity 
and <10ppb total organic carbon, Millipore Milli-Q plus, Billerica, MA, USA) that was 
adjusted to pH 5.0 to protonate residues and maximize charge.  The same procedure was 
used for CP1-cys, which was modified with a cysteine at the C-terminus (≥85% purity, 
New England Peptides).   CP1 and CP1-cys solutions were diluted to 10 μM in PBS for 
all experiments. 
3.3: Motility Test 
 Testing for bacterial flagella was conducted using a motility test (Acumedia 
Manufacturers, Inc., Lansing, Michigan).  Briefly, 22 grams of motility test agar were 
stirred with 1 L ultra pure water and autoclaved.  Media was poured into small vials and 
set for 24 hours.  Bacteria were grown to an absorbance of 0.9 on the spectrophotometer 
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and 2 μl of bacterial solution was injected down the center of each vial.  When the 
motility test agar became cloudy to the edge of the tube, the bacteria expressed flagella.    
3.4: Live/Dead Kit Technique 
 
 The viability of bacteria attached to gold, gold CP1-cys, silicon nitride crystals, 
and silicon nitride CP1 were quantified.  Following peptide adsorption, bacterial solution 
was pumped through the QCM-D and crystals were rinsed with PBS until frequency and 
dissipation equilibration.  Quartz crystals were submerged in 4 ml PBS to avoid cellular 
dehydration.  A BacLight™ live/dead kit (Molecular Probes, Faraday, CA) was used to 
quantify bacterial retention and viability on the substrate containing adsorbed peptide.  
Syto 9 and propidium iodide, diluted in dimethyl sulfoxide (DMSO) (Sigma, St. Louis, 
MO, USA), were added to the 4 ml PBS + quartz crystal to yield final concentrations of 
0.835 μM and 0.5 μM, respectively.  A 60x objective equipped with FITC and Texas Red 
filters were used to capture bacterial images and the accompanying software Spot 
Advanced was used to capture and merge the pictures. (Nikon Eclipse E400; Mercury-
100W lamp, Chiu, Technical Corp).  Experiments were carried out in triplicate for 
reproducibility.   
3.5: Atomic Force Microscopy 
 Glass slides were cleaned measuring ~1 cm x 1 cm. Slides were rinsed with 
copious amounts of ultra pure water (18.2 MΩ cm resistivity and <10ppb total organic 
carbon; Millipore Milli-Q plus, Billerica, MA, USA), followed by sonication for 15 mins.  
Slides were immersed in 3:1 (vol/vol) HCl / HNO3 solution for 30 mins, followed by 
rinsing with ultra pure water.  Slides were soaked in piranha solution (7:3 (vol/vol) 
H2SO4/H2O2 solution) for 30 mins followed by rinsing with ultra pure water.  Glass slides 
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were then immersed in 30/70% 3-aminopropyltrimethoxysilane/methanol (Sigma-
Aldrich) and rinsed with methanol and ultrapure water.  
 A 10 ml vial of bacterial solution was combined with 300 μl of 100 mM 1-ethyl-
3-(3-dimethylaminopropyl) carbodimide hydrochloride (pH 5.5, EDC, Pierce).  The vial 
was set on a rotator for 10 mins to equilibrate.  Following EDC treatment, 300 μl of 40 
mM N-hydroxysulfosuccinimide (pH 7.5, Sulfo-NHS, Pierce) was combined with the 
bacterial solution for another 10 mins.  Bacterial solution was poured over glass slides 
and agitated at 40 rpm for 10-12 hours to promote a well spread bacterial lawn.     
Silicon nitride probes were cleaned by immersion in 100% ethanol for 1 hour 
followed by UV treatment (365 nm) to remove organic films. Spring constants of the 
silicon nitride cantilevers were measured using a thermal calibration method, and were 
found to be 0.07 ± 0.01 N/m
248
.  The AFM was a Digital Instruments Dimension 3100 
with a Nanoscope III Controller (Santa Barbara, CA).  Images were captured in 
intermittent contact mode in PBS to mimic physiological conditions. The scan rate was 1 
Hz and images were captured with 512 x 512 resolution.  For each strain, 10 cells probed 
and 5 force profiles were captured for each one; hence 50 force curves were analyzed per 
condition.  Each force profile contained 512 data points.  Fadh was measured from the 
retraction portions of the force cycles.  Prior to and following a force cycle on a 
bacterium, force measurements were made on a clean glass slide.  If a single sharp peak 
was observed at ~0-5 nm, then the probe was considered clean and could be used for 
subsequent experiments.  Loading rate, which is the product of spring constant and 
retraction velocity
249
, was measured as 864 nN/s.   
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AFM was used for conducting force profiles between bacterial LPS and silicon 
nitride probes or modified probes with cecropin P1 (CP1) (≥ 85% purity, New England 
Peptides, Gardner, USA).  Probes were modified by immerging silicon nitride tips 
(DNPS, Veeco Instruments, Inc, CA) in 10 μM CP1/PBS solution.  Adhesion was 
monitored with the QCM-D under similar conditions to characterize deposition 
(discussed in depth in the QCM-D section). 
Force profiles were analyzed by exporting the ASCII files to a Matlab to make the 
constant compliance region aligned with the „Y‟ axis and the zero interaction region to 
align with the „X‟ axis.  Such calibration was carried out for both the approach and 
retraction curves.  The forces required to overcome attraction forces between the silicon 
nitride probe and sample were recorded, as is illustrated in Figure 3.1. 
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Figure 3.1 Bare Tip with E. coli O157:H12 
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While the AFM has become the instrument of choice for studying in-depth studies 
of biological samples, external noise can be registered in both the approach and retraction 
profiles.  Since the noise level can vary due to mechanical vibrations and other external 
sources, AFM force profiles were captured either before 9 am or after 6 pm.  The 
measured noise level was found to be 0.05 nN, which meant peaks occurring at or below 
that level were random events and not included in the final analysis. 
 Approach curves were modeled to account for steric interactions.  During 
approach of the tip to the bacterial membrane, the AFM tip must overcome steric 
hindrance due to the overlapping of electron clouds
250
 of the LPS on the bacterial 
membrane.  Approach curves were fit with the models of Alexander
251
 and de Gennes
252
, 
as modified by Butt et al for AFM analysis
253
. 
                                                       
 
where, F is the steric force, F0 is the force at zero separation, L is a fitting parameter for 
representing equilibrium polymer brush length, and δ is the tip-sample separation (Figure 
3.2 A & B).   
 Statistical software from SigmaStat (vs. 2.03) and SAS® were employed for 
statistical analysis of the AFM data.  One way ANOVA tests were used to compare 
retraction force profiles with bare silicon nitride probes to CP1 coated tips.  In addition, 
SAS software was used to conduct normality tests for the steric modeling and to grasp a 
better understanding of the variability of the E. coli LPS.   
 
 
(51) 
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Figure 3.2. Representative approach curves for E. coli O157:H7.  A. Representative 
approach curve on a single bacterium.  B. Steric modeling of approach curve, with slope 
of fitting line equal to -2π/L.  Zero separation and zero interaction regions of the 
approach curves are not incorporated into the steric model. R
2
>0.90 for all steric 
modeling.  Based on equilibrium fit, LPS length is 49 nm. 
 
B 
A 
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3.6: Zeta Potentials 
 The zeta potential for each of the 13 strains was measured using a zeta potential 
analyzer (Zetasizer Nano ZS; Malvern Instruments, Worcestershire, UK).  E. coli were 
washed 3 times in PBS to remove growth media..  Cells were diluted to a concentration 
of 1 x 10
8
 cells/ml and injected in a folded capillary cell (DTS1060; Malvern 
Instruments).  Three rounds of at least 10 measurements (100 max) were conducted to 
ensure reproducibility.  Between each round the solution equilibrated for 2 mins.  Using 
the Smoluchowski Equation
247
 the electrophoretic motilities and surface potentials were 
converted to Zeta potentials to better understand the extent of the negative charge of the 
bacteria.    
 Ten μM CP1-cys and CP1 solutions were measured in PBS.  Peptide solutions 
were injected into folded capillary cells and three replicates of at least 10 measurements 
were made.   
3.7: Contact Angles 
 Bacteria were grown to the late exponential phase of 0.9 absorbance and 20 ml of 
bacterial suspension was centrifuged at 190 x g and washed 3 times in PBS.  By the final 
rinse, the bacterial solution was concentrated to below 2 ml.  The solution was pumped 
through a 0.45 μm filter (Membrane Filters, Millipore, MA) to trap bacteria on the 
surface.  Three filters per bacterial strain were prepared and resulting contact angles were 
averaged to conduct surface free energy calculations.  Three probe liquids of varying 
polarities were used including ultrapure water, diiodomethane (Alfa Aesar, MA), and 
formamide (J. T. Baker, NJ).  Each droplet was 2 μl in volume and a video monitored 
when the droplet contacted the filter paper, before the liquid could be absorbed by the 
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filter paper.  Contact angles were performed using a Ramé-Hart model 100-00 (Ramé-
Hart, NJ) and analyzed with the DROPimage software (Ramé-Hart, NJ).   
3.8: QCM-D 
 Silicon nitride (Cr, 5 nm, Au, 100 nm, Si3N4, Q-sense, Sweden) and gold (Cr, 5 
nm, Au, 100 nm, Q-Sense, Sweden) AT-cut quartz crystals were used for QCM-D 
experiments.  Silicon nitride crystals were used to simulate CP1 adsorption to the AFM 
probes, while the gold-coated quartz crystals were used to better control adsorption of 
CP1-cys.  CP1-cys binds at the c-terminal where the cysteine residue is located.  This 
method has been widely used to form self assembled monolayers (SAMs)
206, 254, 255
 and 
has also been used to immobilize peptides
256
.   
 Silicon nitride quartz crystals were cleaned in 2% sodium dodecyl sulfate (SDS) 
(Sigma-Aldrich) solution for 30 min, followed by copious rinsing with ultrapure water 
and UV treatment (365 nm) for 30 min.  Nitrogen was used to remove water droplets.  
Gold-coated quartz crystals were cleaned in 5:1:1 ultrapure water, hydrogen peroxide 
(Alfa Aesar), and ammonia hydroxide (Sigma-Aldrich) at 75 C for 30 min.   The gold-
coated crystals were cleaned in the same way.   The E4 (Q-Sense, Sweden) was cleaned 
by mounting cleaning crystals in the chambers prior to and following an experiment.  
Ultrapure water was pumped through each chamber for 20 min at 200 μl/min, followed 
by Hellmanex®II (Sigma-Aldrich) for 20 mins at 100 μl/min, and ultrapure water for 30 
min at 200 μl/min.  Chambers were nitrogen-dried following the rinse cycle. 
 The chamber temperature was set to 23 C prior to each experiment and ultrapure 
water was pumped over the experimental crystals for at least 20 min at 150 μl/min before 
monitoring began.  Once frequency and dissipation monitoring initiated, a baseline with 
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ultrapure water was established before switching to PBS where a new baseline would be 
established.  The pump flow-rate was reduced to 50 μl/min whenever peptide or bacteria 
at a concentration of 1 x 10
8 
cells/ml were introduced to the quartz crystal to promote 
adhesion.  A follow-up rinse at 50 μl/min removed loosely deposited material until 
stabilization in terms of frequency and dissipation. 
 Typically, experiments were conducted by monitoring the 3
rd
, 5
th
, 7
th
, and 9
th
 
harmonics, although the fundamental harmonic was monitored when it was necessary to 
compare data with QCM models than only operated at the fundamental harmonic.  
Resonances were found for each crystal at all specified harmonics.  Table 3.2 displays 
typical values at the differing harmonics.   
 
Table 3.2 Typical Dissipation Values for Operable Crystals 
Harmonic In Air (D 10
-6
) In Liquid (D 10
-6
) 
1 10-50 200-400 
3 10-30 150-250 
5 5-20 100-200 
7 0-20 100-150 
9 0-20 50-150 
    
The chamber temperature was set to 23 C prior to each experiment and ultrawater 
pumped over the experimental crystals for at least 20 mins at 150 μl/min before 
monitoring began.  Once frequency and dissipation monitoring initiated, a baseline with 
ultrawater was established before switching to PBS or 0.01 M phosphate buffer (PB) 
where a new baseline was established.  The pump flow-rate would be reduced to 50 
μl/min whenever CP1 or bacteria was introduced to the quartz crystal to promote 
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adhesion.  A follow-up rinse with PBS at 50 μl/min removed loosely deposited material 
until stabilization in term of frequency and dissipation.     
CP1 was stored in 1.5 ml vials of 100 μM concentrated CP1 at pH 5.5 in ultrapure 
water.  Prior to experiments with trifluoroethanol (TFE) or Tris(2-
carboxyethyl)phosphine hydrochloride (TCEP), CP1 would be thawed and combined 
with phosphate buffer at the desired concentration (Table 3.3).   The concentration of 
TFE was 25% vol/vol and TCEP was dissolved into solution to yield a 50 mM solution.   
Table 3.3 QCM-D Trials to Enhance CP1-cys adsorption to Gold Quartz 
Crystals 
Trial CP1 Concentration Buffer pH Additive 
1 10 μM 0.01 M PB pH 7.4 None 
2 10 μM 0.01 M PB pH 9.2 None 
3 10 μM 0.01 M PB pH 7.4 25% TFE 
4 10 μM 0.01 M PB pH 9.2 25% TFE 
5 10 μM 0.01 M PB pH 7.4 50 mM TCEP 
6 10 μM 0.01 M PB pH 9.2 50 mM TCEP 
7 29.1 μM 0.01 M PB pH 7.4 None 
8 29.1 μM 0.01 M PB pH 9.2 None 
9 29.1 μM 0.01 M PB pH 7.4 25% TFE 
10 29.1 μM 0.01 M PB pH 9.2 25% TFE 
11 29.1 μM 0.01 M PB pH 7.4 50 mM TCEP 
12 29.1 μM 0.01 M PB pH 9.2 50 mM TCEP 
13 0 μM 0.01 M PB pH 7.4 25% TFE 
14 0 μM 0.01 M PB pH 7.4 50 mM TCEP 
 
Modeling of the data was conducted using both the Sauerbrey relation and the 
viscoelastic modeling software accompanying the E4 (Qsoft401 & QTools 2.1.6.134).  
The Sauerbrey relation is useful for determining the areal mass (given fundamental 
frequency), thickness (given density), or density (given film thickness).  The simple 
relation can only take into account a single frequency harmonic in its calculation and is 
valid for only rigid films.  A viscoelastic Voigt Modeling method was used to incorporate 
viscoelastic properties of the film such as dissipation, as well as frequency shifts at 
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multiple harmonics to enhance modeling capability.  The film thickness is calculated with 
Voigt viscoelastic modeling and areal mass be calculated by multiplying by the film 
density (thickness (tvoigt) x density (ρeffective)).   
3.9: AFM Section Analysis vs. QCM-D Voigt Viscoelastic 
Modeling 
  
 Gold quartz crystals were mounted in the QCM-D and the frequency and 
dissipation responses were monitored at ~15, 25, 35, 45, and 55 Mhz, which correlate to 
the 3
rd
, 5
th
, 7
th
, 9
th
, 11
th
 harmonics, respectively.  The temperature was held at 23°C and 
liquid flowrate was constant at 50 μl/min.   
 We employed a model protein, fetal bovine serum (FBS) in 0.01 M phosphate 
buffer saline (PBS), which was adsorbed to gold QCM-D sensors (E4, Q-Sense).  Gold 
sensors were mounted in the QCM-D at 23°C and liquid flowrate was 50 μl/min.  FBS 
was studied at concentrations of 0%, 0.1%, 1%, 10%, and 100% in PBS.  From QCM-D 
raw data, the deposited layer thickness was calculated using Voigt viscoelastic modeling 
for a film in liquid
169, 170
 (See Equations 11-16).        
 Parameters for the Voigt model were set to have the viscosity (kg/ms) between 
0.01 and 100, the shear (Pa) forced between 1000 and 1 x 10
9
, and the film thickness (m) 
forced between 1 x 10
-11
 and 1 x 10
-6
.  The fluid density has a minor impact on the 
modeling and was assumed to be 1000 kg/m
3 
since PBS and water have no appreciable 
difference.  Frequency and dissipative data were input into the Voigt model at the 3
rd
, 5
th
, 
7
th
, and 9
th
 harmonic.  Generally, we tried to achieve Chi squared values of 5 x 10
7
 or less 
when fitting our data to the model.   
 
 
Section 3                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
62 
 Crystals were withdrawn from the QCM-D and imaged with AFM (Dimension 
3100, Veeco Metrology) via tapping mode (TM) in PBS, at a scan rate of 1 Hz.  AFM 
probes were silicon nitride with spring constants of 0.06 N/m (Veeco).  At least three 
height and amplitude (10 μm x 10 μm) images were scanned per condition.  Crystals 
were dried for 2 hours and rescanned using TM AFM in air.  Five thickness calculations 
were performed per image using the section analysis software.  One Way Analysis of 
Variance was used to compare QCM-D thickness calculations with the AFM section 
analysis. A statistically significant difference was defined by P<0.05.    
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4: Results 
4.1: Using QCM-D and AFM to Study Protein Adsorption 
4.1.1 QCM-D Calibration with Ethanol 
  The mixing process that occurs inside the QCM-D chambers was observed by 
switching between water/ethanol.  The level of displacement could be calculated by 
monitoring the overall frequency shift from 0% ethanol to 100%, according to
167
.  
Several flow rates were selected, which were measured at the fundamental frequency for 
comparison (Figure 4.1).   
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Figure 4.1 Frequency Shifts from Water to Ethanol as Measured with the Fundamental 
Frequency A. 50 μl/min, B. 150 μl/min, C. 200 μl/min, and D. 400 μl/min.   
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According to
167
, the minimum frequency shift occurs when 40% of the mixture in the 
chamber is ethanol.  When the frequency reaches a plateau, the ethanol has then 
completely displaced the water.  Since the tubing leading to the 4 crystals is of different 
lengths, each crystal was calibrated (Table 4.1).  
 
Table 4.1 Calibration of Ethanol Reaching and Rate of Mixing Inside the QCM-D 
Chambers 
 Flow Rate Ethanol 
Reaches 
Chamber 
Chamber 40% 
Ethanol Filled 
Chamber 
100% Ethanol 
Filled 
Chamber 1 50 μl/min 6 mins 36 secs 7 mins 48 secs 14 mins 32 secs 
 100 μl/min 2 mins 42 secs 3 mins 24 secs 4 mins 18 secs 
 150 μl/min 1 min 48 secs 2 mins 35 secs 2 mins 58 secs 
 200 μl/min 1 min 15 secs 1 min 33 secs 2 mins 36 secs 
 400 μl/min 42 secs 49 secs 1 min 54 secs 
Chamber 2 50 μl/min 6 mins 30 secs 8 mins 32 secs 14 mins 18 secs 
 100 μl/min 4 mins 10 secs 5 mins 15 secs 6 mins 15 secs 
 150 μl/min 2 mins 0 secs 2 mins 56 secs 4 mins 55 secs 
 200 μl/min 1 min 2 secs 2 mins 3 secs 3 mins 33 secs 
 400 μl/min 33 secs 54 secs 2 mins 4 secs 
Chamber 3 50 μl/min 4 mins 18 secs 5 mins 51 secs 9 mins 15 secs 
 100 μl/min 1 min 20 secs 2 min 25 secs 3 min 16 secs 
 150 μl/min 1 min 10 secs 1 min 58 secs 2 min 42 secs 
 200 μl/min 42 secs 1 min 18 secs 2 mins 3 secs 
 400 μl/min 21 secs 40 secs 1 min 6 secs 
Chamber 4 50 μl/min 4 mins 18 secs 5 mins 51 secs 9 mins 15 secs 
 100 μl/min 1 min 33 secs 2 mins 33 secs 3 mins 25 secs 
 150 μl/min 1 min 6 secs 1 min 49 secs 4 mins 8 secs 
 200 μl/min 48 secs 1 min 12 secs 1 min 53 secs 
 400 μl/min 15 secs 30 secs 57 secs 
   
The profiles from Figure 4.1 largely agree with the experimental and theoretical 
calculations of
167
.  As ethanol begins filling the chamber, there is a steep drop in 
frequency, followed by a more gradual return to the baseline until steadying out as the 
ethanol concentration in the chamber approaches 100% (App A).   
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4.1.2 Adhesion of FBS to Gold: Comparing AFM Section Analysis to Voigt Viscoelastic Modeling 
 FBS was deposited onto gold crystals at subsequently increasing concentrations to 
ascertain the saturation concentration of FBS.   According to Figure 4.2, at 10% FBS 
concentration a maximum layer of ~15 nm of FBS could be deposited.  Indeed, film 
thickness increased marginally from 0.1% FBS to 10.0% FBS as monitored with crystals 
1 and 2.  According to crystals 3 and 4, saturation was achieved when 1% FBS flowed 
into the chamber.  The discrepancy between saturation points may be due to sensitivity 
differentials of the mounted crystals
257
.    
 The 100% FBS solution had noticeable viscosity effects on the frequency and 
dissipation, which is observable when the final rinse reduced the calculated film 
thickness back to the level observed with 10% FBS.  Besides viscosity changes, it is also 
probable that much of the accumulating FBS was loosely attached and washed off during 
the rinse. 
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Figure 4.2 Viscoelastic modeling of the FBS deposition 
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 The literature contains numerous comparative studies with the AFM and QCM-
D
258-260
; however, none have compared the Voigt viscoelastic modeling results with the 
AFM‟s section analysis.  Since the two methods can be used under similar environments 
but each has specific advantages, it is important to ascertain how the thickness of a well-
dispersed film compares depending on the utilized method.  Knowing how the two 
correlate, a user of the AFM‟s section analysis would find the QCM-D‟s real time 
analysis tool advantageous.   
 By comparing thickness calculations with the AFM section analysis versus the 
QCM-D, we found insignificant differences when comparing systems with similar 
quantities of FBS deposition (Figure 4.3).  The QCM-D monitoring found that regardless 
of 1% FBS, 10% FBS, or 100%, surfaces became saturated with FBS in 5-10 mins 
(Figure 4.4).  Although more FBS adhered in the cases of 10% and 100% FBS, the final 
rinse with PBS washed off loosely bound protein such that the final thicknesses were the 
same.   
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Figure 4.3 AFM in Intermittent Contact Mode Liquid Compared to QCM-D Voigt 
Viscoelastic Modeling.  Star represents statistical difference (P<0.05). 
 
 
The only circumstance when there was a discrepancy between QCM-D and AFM was the 
control case when only PBS was introduced to the system.  The disagreement under the 
control case is attributable to the quartz crystal not being perfectly smooth, which yielded 
the height information under the AFM section analysis.   
 Additionally, when changing the liquid media from water to PBS, viscosity 
changes caused a shift in the frequency and dissipation, which the modeling registered as 
film thickness.  Indeed, viscosity differences between liquids is an important parameter to 
consider and can have a major impact on frequency and dissipation data (App A)
167
. The 
FBS solutions will have different viscosities depending on concentration, which impacts 
frequency and dissipation data.  For the case when only PBS flowed over the gold quartz 
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crystal the calculated film thickness was neglected by subtracting the final calculated 
thickness when being rinsed with PBS. 
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Figure 4.4 Voigt Viscoelastic Modeling of FBS Adsorption.  A. 0.1 % FBS / 99.9 % 
PBS, B. 1.0 % FBS / 99.0 % FBS, C. 10 % FBS / 90.0 % PBS, D. 100% FBS.  Each 
deposition process was followed by a rinse with 100% PBS to remove loosely bound 
proteins. 
 
 A final rinsing procedure of PBS is therefore necessary to both remove loosely 
deposited FBS, and to change the viscosity of the surrounding liquid back to that of PBS 
(App B & C).  The QCM-D thicknesses reported herein are the final calculated 
thicknesses minus the thickness calculated when switching from water to PBS. 
 Although the average thicknesses between the QCM-D and AFM under similar 
circumstance were the same, the level of variability in the AFM data is largely due to 
A B 
C D 
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relatively small sample data compared to the overall quartz crystal.  The QCM-D results 
constitute a combination of 3 separate FBS deposition experiments and we attribute the 
smaller error bars to a more systematic and reproducible method of calculating film 
thickness. 
 We also considered the circumstance of AFM quartz crystal analysis in air versus 
QCM-D results that were taken in liquid.  Figure 4.5 compares AFM section analysis in 
air versus the QCM-D results, while Figure 4.6 confirms the significant differences 
between operating in air versus liquid by comparing AFM in liquid to air.  We found the 
topography to be significantly different, which we contribute to crystallization of the PBS 
and aggregation of the protein following drying.  The crystalline features that were 
pronounced on the 0% FBS crystal were not found in the cases with FBS deposition and 
were clearly FBS deposits. Hence, when comparing AFM and QCM-D data, it is essential 
to do so in identical environments. 
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Figure 4.5 AFM in Contact Mode Air Compared to QCM-D Voigt Viscoelastic 
Modeling.  Stars represent statistical difference between AFM and QCM-D analysis on 
the same crystal (P<0.05). 
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  The roughness analysis results correlated well to the respective section analysis 
trend.  Figure 4.7 shows that under each circumstance the RMS roughness was 
significantly greater for environments in air compared to liquid.  This was due to 
crystallation of the PBS and FBS (Figure 4.8). Indeed, comparing Figure 4.8 A & C, the 
features are completely different.  The FBS deposited more rounded deposits onto the 
gold surface, while the salt created flakes on the surface, which is expected for dried salt.   
In liquid, few discernable features are present for protein deposition when compared to a 
non-protein deposition scenario (Figure 4.8 B & C).  
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Figure 4.6 AFM in Intermittent Contact Mode Liquid Compared to AFM Contact Mode 
Air.  Stars represent statistical difference between AFM and QCM-D analysis on the 
same crystal (P<0.05). 
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Figure 4.7 AFM Roughness Analyses of Images Captured in Intermediate Contact Mode 
Liquid and Contact Mode Air 
 
 
 
 
 
 
Figure 4.8 A. 100% FBS AFM Contact Mode in Air.  B. 100% FBS AFM intermittent 
contact mode in liquid.  C. 0% FBS AFM intermittent contact mode in air. D. 0% FBS 
AFM intermittent contact mode in liquid.   (Bars indicate z scale) 
 
A B 
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 As would be expected, higher roughness readings corresponded well to greater 
thicknesses as measured from the section analysis
261
.  In air, the R
2
 value between section 
and roughness was 0.70, which indicates a strong linear trend (Figure 4.9).  In liquid, an 
outlier at 10% FBS concentration resulted in a weak linear correlation of just R
2
=0.28 
(Figure 4.10).  Removing the outlier of 10% FBS yields a linear regression of R
2
=0.95.  
The roughness results were not unusual for protein deposition experiments and further 
confirmed nothing unusual occurred during the FBS deposition
262, 263
.   
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Figure 4.9 AFM Intermittent Contact Mode Liquid; Section Analysis Compared to 
Roughness Analysis 
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Figure 4.10 AFM Contact Mode Air; Section Analysis Compared to Roughness Analysis 
 
 
4.2: Enhancing Adsorption of CP1-cys to Gold 
 The influence of pH on CP1-cys adsorption in terms of areal mass and film 
thickness were investigated (Figures 4.11 and 4.12).   The pH appears to have some 
influence on CP1-cys adhesion.  For the cases of 10 μM concentrated CP1-cys in TFE 
and 29.1 μM CP1-cys without chemical additives, there was no observed difference in 
peptide adsorption.  Areal adsorption was significantly higher for the remaining 
experimental conditions at neutral pH.    Significant differences in areal mass calculations 
were not observed for conditions with similar additives but differing peptide 
concentrations. Therefore, neutralizing the cationic regions of the peptide via pH 
alterations had a minor impact on whether CP1-cys could adhere to gold. 
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Figure 4.11 Areal Units of CP1-cys Adsorption to Gold Quartz Crystals.  Stars represent 
statistical differences when comparing solutions of identical additive and CP1-cys 
concentration but differing pH (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12 Film Thickness of Adsorbed CP1-cys to Gold Quartz Crystals.  Stars 
represent statistical differences when comparing solutions of identical additive and CP1-
cys concentration but differing pH (P<0.05). 
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 Figures 4.13 and 4.14 compare solution CP1-cys concentrations while holding pH 
and additive constant.  In the cases when no additives were involved, the 29.1 μM CP1-
cys solution yielded significantly more areal mass and film thickness.  Similar trends 
were found with the additives TCEP and TFE (Figures 4.13 & 4.14; P<0.05).  For cases 
of no additives, we observed approximately double the CP1-cys density on the gold 
quartz crystals at 29.1 μM versus 10 μM.  The differences were not as significant for 
differing pHs or when additives were present. The QCM-D analysis showed that the 
substrata were saturated at the differing concentrations used, which is indicated via 
frequency and dissipation stability following peptide passivation and a final rinse (App 
C).   
 CP1-cys concentration was important for saturating the gold crystals.  Under most 
circumstances, 29.1 μM CP1 solution yielded greater peptide deposits.  Only in the cases 
of TFE solution at pH 9.2 did saturation not depend on CP1-cys concentration.  For 
neutral PB without additives, the amount of adsorbed CP1-cys increased by 91%, while 
at pH 9.2, the amount of adsorbed CP1-cys increased by 60%.  However, in the case with 
TCEP, adsorbed mass increased by only ~33%, but the net increase of areal mass was 
>100 ng/cm
2
, which is greater than all other circumstances (Figure 4.13).   
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Figure 4.13 Areal Units of CP1-cys Adsorption to Gold Quartz Crystals.  Stars represent 
statistical differences when comparing solutions of identical additive and pH but differing 
CP1-cys concentration (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14 Film Thickness of CP1-cys Adsorption to Gold Quartz Crystals.  Stars 
represent statistical differences when comparing solutions of identical additive and pH 
but differing CP1-cys concentration (P<0.05). 
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 The trifluorethanol runs yielded unexpected degrees of viscosity changes and 
mixing inside the QCM-D chambers (Figure 4.15).  According to the Voigt Modeling, the 
film thickness was greater at the 10 μM CP1-cys concentration than at the 29.1 μM.  We 
attribute these erroneous results to difficulties operating with TFE since the viscosity 
effects appear to be outside the design of the modeling software.  Using more dilute 
concentrations of TFE may enhance modeling for further study.   
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Figure 4.15 QCM-D measurement of TFE and 10 μM CP1-cys to gold quartz crystals.  
From t=0-21 mins, PB flowed over the gold quartz crystal followed with TFE.  From 
t=55-78 mins, CP1-cys + TFE flowed over the gold quartz crystal.  A rinse of TFE 
followed peptide adsorption and at t=95 mins the crystal was rinsed with PB to remove 
loosely deposited peptide. 
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 Comparisons between the effects of additives show significant increases for when 
TCEP was present (Figure 4.16 and 4.17).  TCEP was found to adhere to the gold 
substrates, therefore areal mass calculations of peptide adsorption accounted for the 
adsorption of TCEP (Figure 4.18 & 4.19).  In terms of the areal mass, TCEP enhanced 
the adhesion of CP1-cys regardless of pH.  TCEP in concert with neutralized cationic 
regions may have the desired effect of enhancing CP1-cys orientation to gold, but did not 
significantly affect adhesion and retention.   
 Thickness calculations were more inconclusive since TFE was difficult to model, 
however the additive TCEP was easier to model.  When TCEP passivated the gold quartz 
crystal, we observed increased CP1-cys film thickness and more vertically oriented 
peptide on the gold than without the additive.  This is due to dissipation increasing and 
frequency decreasing significantly more than compared to without additive.  TCEP 
improved binding between peptide and gold even at the higher pH, which indicates the 
lysines had a lesser role in peptide adhesion. TFE resulted in no increased CP1-cys 
adsorption and dissipation results are difficult to quantify due to bulk shifts in viscosity 
and density. 
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Figure 4.16 Areal Mass of CP1-cys Adsorption to Gold Quartz Crystals.  Stars represent 
statistical differences when comparing solutions of identical CP1-cys concentration and 
pH but differing additive (P<0.05). 
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Figure 4.17 Film Thickness of CP1-cys Adsorption to Gold Quartz Crystals.  Stars 
represent statistical differences when comparing solutions of identical CP1-cys 
concentration and pH but differing additive (P<0.05). 
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Figure 4.18 Frequency and Dissipation response to TCEP adsorption to gold quartz 
crystal in PB.  From t=0-13 min, PB flowed over crystals.  From 13 min to 70 min TCEP 
solution was introduced, which was followed by rinsing with PBS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19 Frequency and Dissipation response to TCEP + CP1-cys adsorption to gold 
quartz crystal in PB.  From t=0-13 min, TCEP solution flowed over crystals.  From 13 
min to 38 min TCEP + CP1-cys was introduced, which was followed by rinsing with 
PBS.  Frequency and dissipation data from Figure 4.18 was subtracted from analysis so 
that the effects of adsorbed TCEP were not included in quantifying adsorbed peptide.   
PBS TCEP PBS 
TCEP TCEP + CP1-cys PBS 
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4.3: Bacterial Adhesion + Properties of LPS 
4.3.1 Motility Test 
 The 13 E. coli strains expressed flagella when the serotype specified flagella 
production (Table 4.2).  These results are expected, and demonstrate that the storage and 
growth of the E. coli had no adverse side effects on the bacteria.   
 The motility test is a simple indication of whether the E. coli strains express 
flagella.  After 24 hr since inoculation, bacteria possessing flagella will be able to 
colonize agar within several millimeters.  There are some important parameters to 
consider.  The agar needs to be fresh and be solid enough to hold form, but be easily 
pierced by an inoculation loop.  Additionally, temperature is important to consider or else 
the bacteria may not be in condition to use the flagella.  For example, Yersinia 
enterocolitica is motile between 20-25°C but not outside this range
264
.  Since the results 
comply with the bacterial serotypes, these results demonstrate the rinsing procedure, 
which includes vortexing, did not cause significant damage to the bacteria. 
Table 4.2 Motility Test Results for 13 E. coli Strains 
Strain Motility 
E. coli HB101 NO 
E. coli K12 NO 
E. coli ML35 NO 
E. coli O26:K60:H11 YES 
E. coli O35:H10 YES 
E. coli O55:H7 YES 
E. coli O113:H4 YES 
E. coli O113:H21 YES 
E. coli O117:K98:H4 YES 
E. coli O157:H7 YES 
E. coli O157:H12 YES 
E. coli O157:H16 YES 
E. coli O172:H- NO 
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4.3.2 Steric Model on E. coli to Determine LPS Length 
 Steric repulsion was observed in all approach curves.  The distance from the 
bacterium to the AFM probe at which repulsive forces were encountered varied for each 
strain.  The variations in approach curves are reflected in differences of LPS length 
(Table 4.3) and distribution of these data (Table 4.4).  The steric model was applied to the 
approach curves (Fig 3.2 A) and an R
2
 >0.90 was achieved for all data (Fig 3.2 B).  Data 
from the zero interaction and 0 seperation regions of the approach curves were not 
considered for steric modeling.   
 
 
 
  
  
 
Strain 
Equilibrium 
Length (nm) 
Core Type 
Absolute 
Adhesion 
Force (nN) 
 
HB101 5± 3 K12 0.4 ± 0.1 
 
 
K12 3 ± 2 K12 0.5 ± 0.2 
 
 
ML35 3 ± 2 K12 0.7 ± 0.4 
 
 
O26:K60:H11 15 ± 5 R3 0.2 ± 0.1 
 
 
O35:H10 39 ± 14 NA 1.0 ± 0.5 
 
 
O55:H7 38 ± 10 R3 0.9 ± 0.4 
 
 
O113:H4 17 ± 10 R3 0.6 ± 0.6 
 
 
O113:H21 37 ± 9 R1 1.0 ± 0.4 
 
 
O117:K98:H4 40 ± 12 NA 1.3 ± 0.6 
 
 
O157:H7 30 ± 13 R3 0.7 ± 0.4 
 
 
O157:H12 25 ± 9 R2 0.6 ± 0.2 
 
 
O157:H16 19 ± 6 R2 0.5 ± 0.2 
 
 
O172:H- 41 ± 12 R3 1.5 ± 0.7 
 
 
       
  
 The LPS lengths were the shortest for the three strains that lacked the O-antigen: 
HB101, K12, and ML35.  Average LPS lengths of control strains, which are composed of 
the lipid A and core polysaccharide, was 3.5 nm.   Averaged equilibrium polymer lengths 
Table 4.3 Bacterial LPS properties  
   
Core types from Amor et al 
1
.  Bold text represents control K-12 strains that do 
not express the O-antigen.  Force cycles with bare silicon nitride probe. 
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for control strains were statistically similar based on the ANOVA test (P=0.92). By 
applying steric modeling to the approach curves of the 5 O-antigen expressing strains, we 
could make quantitative comparisons based on LPS characteristics.  LPS lengths varied 
from 17 to 37 nm for strains with O-antigens (Table 4.3).  E. coli with the same O-
antigen sugar composition had significantly different LPS lengths.  For example, the 
lengths for O157:H7 when compared to O157:H12 and O157:H16 were significantly 
different (P<0.05).  The two O113 serotypes had LPS lengths of 17 ± 10 nm (for 
O113:H4) and 37 ± 9 nm (for O113:H21).  This difference of 20 nm was statistically 
different (P<0.05).  Further, LPS lengths of the control strains were significantly shorter 
compared to all O-antigen expressing strains (P<0.05).   
4.3.3 Shapiro-Wilk Test for LPS Length Distribution 
 Another method for exploring the differences of the bacterial LPS is by 
conducting a Shapiro-Wilk Test for normal distribution (Table 4.4)
265-267
.  The test 
assumes that a large sample relative to the overall population has been taken and the 
results serve as an indication of whether the bacterial surface is homogenous.  Approach 
curves corresponding to retraction force curves that were found to be outliers in terms of 
retraction distance were removed (App D).   
 The normality test was conducted for the 13 E. coli strains and is based on data 
obtained for length.  Nearly all bacteria were normally distributed in terms of their 
polymer lengths.  Even strains that possessed the highly variable O-antigen distribution 
of the LPS length was normal.  These results indicate suffificent sample size was 
achieved to grasp an overall understanding of the E. coli LPS.  Only E. coli 
O26:K60:H11 and O113:H4 had abnormally distributed LPS.  These two strains also had 
 
 
Section 4                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
84 
the shortest averaged LPS length, but it remains unclear if increasing the sample size 
would have resulted in a more normal distribution of data.  Instead of 50 force curves that 
probe 10 bacteria selected from a population of billions, it may be advantageous to take 
significantly more data by conducting „force mapping‟ of hundreds or thousands of 
bacteria within a sample to more accurately ascertain the distribution of LPS length
268-270
.    
 
Table 4.4 Shapiro Wilk Test for Normality of the Polymer Length for the 13 E. coli 
Strains 
  
    
 
 
          Length   
 
 
Serotype W
a Normal 
Distribution 
 
 
E. coli HB101 0.89 Yes 
 
 
E. coli ATCC 29425 0.92 Yes 
 
 
E. coli ML35 0.96 Yes 
 
 
E. coli O26:K60:H11 0.80 No 
 
 
E. coli O35:H10 0.97 Yes 
 
 
E. coli O55:H7 0.98 Yes 
 
 
E. coli O113:H4 0.80 No 
 
 
E. coli O113:H21 0.90 Yes 
 
 
E. coli O117:K98:H4 0.95 Yes 
 
 
E. coli O157:H7 0.91 Yes 
 
 
E. coli O157:H12 0.96 Yes 
 
 
E. coli O157:H16 0.96 Yes 
 
 
E. coli O172:H- 0.96 Yes 
 
 
 
     
  
4.3.4 E. coli Adhesive Forces with Silicon Nitride 
 The adhesion force analysis provides the forces required to overcome adhesive 
forces between LPS molecules and silicon nitride probe.  Once the probe contacts the 
LPS, polymers attach to the silicon nitride tip causing multiple polymer breakages.  The 
detachment of the polymers occurs at differing points due to Brownian motion of the 
AFM probe
160
; hence there are commonly multiple pull-off events of varying Fadh.   
aNormal Distribution Defined by W≥0.89 
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 Each E. coli strain had a different Fadh with the silicon nitride.  Even for the 
control strains, there were some differences in the adhesion to the AFM tip.  Absolute 
adhesion forces for HB101, K12, and ML35 were 0.4 ± 0.1 nN, 0.7 ± 0.4 nN, and 0.5 ± 
0.2 nN, respectively (Table 2).   E. coli ML35 adhered significantly greater to silicon 
nitride than HB101 and K12 (P<0.05). 
 Of the 10 O-antigen expressing strains, only E. coli O35:H10, O113:H21, 
O117:K98:H4, and O172:H- adhered significantly greater to silicon nitride than the 
control strains (Figure 4.20).  Bacteria among the same serotype were expected to have 
similar adhesion forces due to identical chemical O-antigen compositions.  Our 
hypothesis held true for O157:H7 and O157:H12, however, retraction forces were 
significantly less for O157:H16 (P<0.05).  Absolute adhesion forces for the 3 strains were 
0.7 ± 0.4 nN, 0.6 ± 0.2 nN, and 0.5 ± 0.2 nN, respectively.  However, the O113 serotype 
differed with O113:H21, having significantly greater retraction forces than O113:H4 
(P<0.05). 
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Figure 4.20 AFM Retraction Force Analyses on Bare Silicon Nitride Probes.  Stars 
represent statistical difference between K12 strains and O-antigen containing strains 
(P<0.05). 
 
4.3.5 Effect of Core Types 
 The core type had little effect on Fadh, with Fadh values being statistically similar 
for K12, R2, and R3 cores (Figure 4.20).  Fadh seemed larger for the R1 core strain 
(O113:H21), but we could not make a comparison since no other strain had an R1 core 
(Table 4.3).  The control strains that express the K12 core had conserved equilibrium 
polymer lengths significantly shorter than bacteria of the R1, R2, and R3 core types 
(P<0.05).  However, R1, R2, and R3 strains also expressed the O-antigen that we 
associated with the longer LPS. 
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4.3.6 Correlating LPS Length to Fadh with Silicon Nitride 
 There was no correlation between fitted LPS length and Fadh with silicon nitride 
for any of the control strains.  For strains O113 and O157, Fadh values correlated 
positively with LPS length (Table 4.5).  The strongest correlations were observed for 
O157:H7 and O157:H12 (R
2
>0.90).  Strain O157:H16, which expressed the shortest LPS, 
had a weak correlation (R
2
=0.54). 
 When we grouped strains according to whether they expressed the O-antigen, 
average LPS lengths correlated well with average Fadh for O-antigen expressing strains 
(R
2
=0.84) (Table 4.5).  However, when no O-antigen was present, the correlation was 
poor (R
2
=0.30).  By correlating mean Fadh for all strains with LPS length yielded a 
positive correlation with R
2
=0.53.  The weaker overall trend was due to the control 
strains that appeared to bind to the AFM probe independently of LPS length.   
 
Table 4.5. Bacterial LPS properties measured from steric modeling. 
Strain 
Equilibrium 
Length (nm) 
Core Type1 Fadh (nN) 
Linear Trend  
(Fadh versus LPS Length) 
HB1012 5 ± 3 K12 0.4 ± 0.1 Control Strains y=0.79-0.08x 
K12 3 ± 2 K12 0.5 ± 0.2 
 
R2=0.30 
ML35 3 ± 2 K12 0.7 ± 0.4     
O113:H4 17 ± 10 R3 0.6 ± 0.6 O-antigen Strains y=0.07+0.02x 
O113:H21 37 ± 9 R1 1.0 ± 0.4   R2=0.84 
O157:H7 30 ± 13 R3 0.7 ± 0.4 
 
 O157:H12 25 ± 9 R2 0.6 ± 0.2 All Strains
3 y=0.42+0.01x 
O157:H16 19 ± 6 R2 0.5 ± 0.2   R2=0.54 
 
      
 
 
1
Core types from Amor et al 
1
.   
2
Bold text represents control K12 strains that do not express the O-antigen. 
3
Only E. coli with strains that have O-antigens identical to at least one other 
strain was included.   
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4.4: Bacterial Interactions with Peptide 
4.4.1 Non-specific Binding of CP1 to Silicon Nitride  
 QCM-D was used to monitor the adsorption of CP1 to silicon nitride and gold.  It 
is expected that CP1 will bind non-specifically to either substrate.  On silicon nitride, 
CP1 adsorbed to the substrate rapidly, as indicated by a drop in frequency and an increase 
in dissipation as soon as CP1 was added (Figure 4.21 A).    Saturation was usually 
reached 5-10 min following introduction of CP1 solution.    While frequency dropped by 
20 Hz, dissipation increased by only ~7.0 x 10
-7
.  Using the Voigt viscoelastic model, the 
maximum film thickness of 1.7 nm was calculated at 12 min, but this number includes 
changes of the bulk solution‟s viscosity and density, as well as effects of adsorbed mass 
on the crystal (Figure 4.21 B).  During the rinse phase, loosely deposited peptide was 
removed and the film thickness of CP1 was 1.15 nm at the end of the experiment (Figure 
4.21 B).  Frequency increased by10 Hz during the rinse, but dissipation changed little.   
 Based on a film thickness of 1.15, the areal mass was calculated (ρCP1 =1100 kg 
∙m-3=1.26 x 10-12 ng x 1.15 nm-3=1.26 x 10-12 ng nm-2 [areal density].  MWCP1 ~3338 g 
∙mol-1=1.8 x 1011 CP1unit ∙ng
-1
.   1.26 x 10
-12 ng ∙nm-2 x 1.8 x 1011 CP1unit ∙ng
-1
= 2.3 x 10
-1
 
CP1unit ∙nm
-2
).  This corresponds to 0.23 units of CP1 nm
-2
 adhering to the silicon nitride.   
Unmodified peptide should also bind non-specifically to gold, as was monitored by 
QCM-D (4.22 A & B).  The areal mass and thicknesses of adsorbed peptide were almost 
identical to that on silicon nitride, at 0.22 units of CP1 nm
-2 
and 1.11 nm, respectively.   
4.4.2 Binding of CP1-cys to Gold Quartz Crystals 
 By using cysteine-terminated cecropin P1 (CP1-cys), we determined how the 
peptide adsorbed to gold when covalent bonds were forming (Figure 4.23 A).  From zero 
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to 18 min, PBS was pumped through the chamber, followed by a 14 min addition of CP1-
cys solution (until we visually observed that equilibration was reached).  Frequency 
dropped by ~23 Hz and dissipation increased by 3.4 x 10
-6
.  Following the rinse, the areal 
mass of adsorbed peptide was calculated as 1.9 ng nm
-2
 or 0.34 units of CP1-cys per nm
2
, 
while film thickness was calculated to be 1.70 nm (Figure 4.23 B).  Qualitatively, the 
shape of the frequency and dissipation curves continued to mirror each other. By the 
conclusion of the rinse, frequency had increased by 3 Hz for a net change of 20 Hz, and 
dissipation had a net decrease of 2.8 x 10
-6
.  When covalent bonds could form, CP1-cys 
bonded ~55% more and packed more tightly on the gold crystals than for CP1 
physisorbed to silicon nitride. 
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Figure 4.21 Monitoring attachment of CP1 to silicon nitride.  A) Monitoring frequency 
and dissipation for PBS, followed by addition of 10 μM solution of CP1, and rinse with 
PBS.  Frequency and dissipation changes were monitored with the 3
rd
, 5
th
, 7
th
, and 9
th
 
harmonics.  B) Voigt viscoelastic monitoring of the frequency and dissipation data was 
used to calculate the peptide layer thickness on silicon nitride.  Areal adhesion for CP1 on 
silicon nitride is 0.23 units of CP1 nm
-2
.    
A 
B 
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Figure 4.22 Monitoring attachment of CP1 to gold.  A) Monitoring frequency and 
dissipation for PBS, followed by addition of 10 μM solution of CP1, and rinse with 
PBS.  Frequency and dissipation changes were monitored with the 3
rd
, 5
th
, 7
th
, and 9
th
 
harmonics.  B) Voigt viscoelastic monitoring of the frequency and dissipation data was 
used to calculate the peptide layer thickness on silicon nitride.  Areal adhesion for CP1 
on gold is 0.22 units of CP1 nm
-2
.    
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Figure 4.23 Monitoring attachment of CP1-cys to gold.  A) Monitoring frequency and 
dissipation for PBS, followed by addition of 10 μM solution of CP1, and rinse with 
PBS.  Frequency and dissipation changes were monitored with the 3
rd
, 5
th
, 7
th
, and 9
th
 
harmonics.  B) Voigt viscoelastic monitoring of the frequency and dissipation data was 
used to calculate the peptide layer thickness on silicon nitride.  Areal adhesion for CP1-
cys on gold is 0.34 units of CP1-cys nm
-2
.    
Adhesion of CP1-cys 
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4.4.2 CP1 and Silicon Nitride Interaction with Glass 
 Retraction force curves conducted with bare silicon nitride and modified tips with 
CP1 led to significantly greater pull-off forces for 10 of the 13 E. coli strains (P<0.05).   
These results were based on 50 force curves per condition and were conducted in liquid 
to avoid capillary forces from affecting the pull-off force
271
.  In addition, the pull-off 
force with bare glass was significantly greater between bare glass and silicon nitride than 
with the modified AFM probe (Figure 4.24).  Considering all had a single sharp peak in 
the range of 0-5 nm, the curves demonstrate no specific adhesion occurs between glass 
and AFM probes and that the glass slides were properly cleaned Figure (4.25 A & B).   
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Figure 4.24 AFM Retraction Force Analyses on Bare Glass.  Stars represent statistical 
difference between bare and CP1 modified probe (P<0.05). 
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Figure 4.25 Five Approach and Retraction Force Curve Interactions of Bare Glass with 
A. Silicon nitride and B. CP1. 
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 Since CP1 has a net +5 charge, we expect the modified tip to have an enhanced 
ability to adhere to glass through electrostatic interactions.  The fact that the retraction 
force profile is of a single sharp peak indicates the CP1 layer is very thin and rigid film, 
which correlates well with the QCM-D data.  Steric repulsion forces based on the decay 
lengths were negligible under both conditions, which we expect for a stiff surface without 
polymers extending from a surface
232, 272
.    
4.4.3 Molecular Investigation of Bacterial Adhesion to the Peptide CP1 
 This study comprised of three control strains; HB101, K12, and ML35.  None 
have flagella or an O-antigen and all possess the same core type (App E).  The force 
profiles (App F & G) show that the retraction forces extend upward to 400 nm.  The pull-
off events were commonly comprised of multiple peaks, which are caused by multiple 
polymers on the bacterial membrane temporarily binding to the AFM probe.  The 
retraction force profiles are random events caused by numerous factors: contact points, 
polymer density and length of the bacterium at the point of contact, proteins, LPS, or pili 
that may be probed on the surface, preparation for the binding of bacteria to glass, etc.  
The AFM was used to measure adhesion forces between each bacterial strain and a probe 
that was either uncoated silicon nitride, or silicon nitride with physisorbed CP1.  The 
average force of adhesion (Fadh) between E. coli and the CP1 probe was significantly 
greater than adhesion to bare silicon nitride for 9 of the 13 strains (Figure 5; P<0.05). 
 E. coli HB101 and K12 retraction forces occurred at roughly the same pull-off 
distances of below 200 nm for both silicon nitride and CP1 modified probes (App G).  
The strongest absolute adhesion forces occurred with the modified CP1 probe 0.5 nN and 
1.0 nN, respectively, compared to silicon nitride of 0.4 nN and 0.7 nN (Figure 4.26).   
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Figure 4.26 AFM Retraction Force Analyses on Control Strains.  Stars represent 
statistical difference between bare and CP1 modified probe (P<0.05). 
 
 Of the 10 O-antigen containing strains, 7 displayed greater adhesion forces with 
the CP1 modified probe than with the bare silicon nitride probe.  The strains showing 
statistically significant preference to CP1 included O26:K60:H11, O113;H21, 
O117:K98:H4, O157:H7, O157:H12, O157:H16, and O172:H- (P<0.05).  E. coli 
O35:H10, O55:H5, and O113:H4 were not statistically different when comparing bare 
silicon nitride to CP1 probes (P<0.05).   
 A steric model was used to calculate LPS lengths of the bacterial strains, based on 
modeling the approach profiles of the interactions between a bare silicon nitride tip and a 
bacterium on a glass slide.  We have previously applied this method to estimate LPS 
lengths for E. coli and other bacteria
273
.  When all the strains were grouped together, it 
was difficult to observe any trend between LPS length and the adhesion force with the 
peptide-covered AFM tip (Figure 27 A).  However, for certain subgroupings, we 
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observed weak positive correlations between LPS length and Fadh between the bacterium 
and CP1 (Figure 27 B & C).  When either the O113 or O157 strains were compared 
against the control strains, longer LPS length was associated with increased adhesion 
forces with the peptide CP1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.27 Correlating absolute adhesion force with equilibrium LPS length for all E. 
coli strains.  Silicon nitride AFM probes were functionalized with CP1 to measure Fadh, 
however, steric modeling was conducted using a bare probe and analyzed with Equation 
1. A) Comparison of all strains Fadh versus calculated LPS length.  B) Comparison of 
O113 strains Fadh versus LPS length.  C) Comparison of O157 strains Fadh versus LPS 
length.     
A 
B 
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4.4.4 Force Profiles with Strains Lacking Comparable O-antigens 
 The 5 strains; O26:K60:H11, O35:H10, O55:H7, O117:K98:H4, and O172:H- 
varied in terms of significance in the case of CP1 adhesion when compared to the bare 
silicon nitride probe.  Strain O172:H- had the furthest pull-off forces, extending upward 
to ~700 nm.  On average, O172:H- had pull-off distances of 272  ± 139 nm and 274 ± 
187 nm for silicon nitride and CP1.  Such distances are quite significant, when 
considering the LPS for O172:H- is only 41 nm, which means the LPS was being 
extended upwards to 13 times the nominal length.  Although pull-off distances were 
comparable, the absolute adhesion forces were more muted with the silicon nitride (1.5 ± 
0.7 nN versus 2.0 ± 1.1 nN).  The LPS length was 41 ± 12 nm with an estimated O-
antigen length of 37 nm.  This finding is within the same range found with the O157 
strains and correlates well within the expected range for the O-antigen length having an 
impact on adhesion force.  Indeed, strain O26:K60:H11 has the shortest LPS length of 15 
± 4 nm and also had comparably small absolute adhesion forces (0.5 ± 0.2 nN and 0.2 ± 
0.1 nN).   
 Strains O35:H10 and O55:H7 had LPS lengths of 23 nm longer than 
O26:K60:H11 and both strains encountered no significant difference in adhesion to 
silicon nitride and CP1 (P<0.05).  Whether the LPS length, sugars comprising the O-
antigen, or some other mechanism were responsible for the resulting adhesion is unclear 
without other strains of the same O-antigen.   
 That strain O117:K98:H4 had a longer slightly longer LPS (40 nm) than O35:H10 
and O55:H7, which may have enhanced the adhesion of CP1 versus bare silicon nitride 
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(0.6 ± 0.2 nN vs. 1.7 ± 0.9 nN).  The binding results of O117:K98:H4 differ significantly 
with those of O55:H7 under both scenarios, however, under neither case did 
O117:K98:H4 differ significantly from O35:H10 (P<0.05).   
4.4.5 O-antigen Probing with Silicon Nitride versus CP1 
 The AFM was used to measure Fadh between silicon nitride probes and probes that 
have been modified with the addition of CP1.  Fadh was significantly greater for 10 of 13 
strains (P<0.05).  We observed greater Fadh for all control strains, O113:H21, all O157 
strains, O26:K60:H11, O117:K98:H4, and O172:H-.  Although Fadh was ≥ for when CP1 
was present, the differences for strains O113:H4, O35:H10, and O55:H7 were not great 
enough to be considered statistically significant (Figure 4.28). 
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Figure 4.28 AFM was used to measure Fadh between E. coli and silicon nitride probe, or 
the silicon nitride probe that was pre-functionalized with CP1.  Each bar represents 
absolute adhesion forces measured from 50 force cycles per bacterial strain.  Stars 
represent significant difference between adhesion force of bacteria with silicon nitride 
and adhesion force of bacteria with CP1-tip (P<0.05).   Bars to the right of solid black 
line represent E. coli strains expressing O-antigen. 
  
4.4.6 Fadh O-antigen Strains Comparison to Control Strains 
 Eight of the O-antigen strains adhered significantly better to CP1 than compared 
to the averaged adhesion force of the control strains; HB101, K12, and ML35.  All of the 
O157 strains adhered significantly better to CP1 than the K12 strains.  This differs from 
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probing with silicon nitride, where none of the strains differed significantly.  Only strains 
O26:K60:H11 and O113:H4 did not differ significantly from the control (Figure 4.29).   
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Figure 4.29 AFM Retraction Force Analyses of CP1 Modified Probe.  Stars represent 
statistical difference between K12 strains and O-antigen containing strains (P<0.05).   
  
4.4.7 Bacterial Retention and Viability on Cecropin P1 Surfaces 
 The effectiveness of an adsorbed peptide on bacterial inactivation was quantified 
by comparing bacterial viability when interacting with CP1 physically adsorbed to silicon 
nitride, or with CP1-cys covalently bound to gold.  Since the control surfaces are 
different (bare silicon nitride vs. bare gold), the bacterial inactivation to a peptide-bound 
surface was always compared to that same surface, but containing no peptide.   
 E. coli attached more to the CP1-cys on gold than to bare gold for 9 of the 13 
strains studied (Figure 4.30 A).  The attachment of the three control strains was generally 
lowest.  Gold has a relatively high antimicrobial activity (Figure 4.30 B; green bars), but 
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in 4 of the 13 strains studied (O113:H4, O157:H7, O157:H12, and O35:H10), we still 
saw a significantly significant increase in the percentage of dead bacteria on CP1-cys 
gold than on peptide adsorbed to gold (Figure 4.30 B; blue bars).  Strains O113:H4 and 
O35:H10 were most susceptible to the effects of peptide, as four times as many bacteria 
were dead on the peptide-coated gold surface than on bare gold.  None of the control 
bacterial strains (lacking O-antigen) showed differences in their viability on gold vs. 
CP1-cys coated gold, although all showed differences in attachment of bacteria per area.     
 On silicon nitride, to which the peptide adsorbed non-specifically, 6 of the 13 
strains attached more to the CP1-coated surface than to uncoated silicon nitride (Figure 
4.31 A).  For O157 strains, we observed 25-65% increases in E. coli adhesion to CP1 
compared to on silicon nitride, with the largest increase observed for strain O157:H21.  
However, in contrast to the results seen on gold for the covalently bound CP1, all 13 
strains had significantly reduced viability on the CP1 silicon nitride, compared to 
uncoated silicon nitride (Figure 4.31 B).   For all but one strain, >50% of bacteria were 
killed when attached to the CP1 coated silicon nitride.   Bare silicon nitride caused low to 
moderate killing of attached bacteria.   
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Figure 4.30 Comparing A) whole-cell binding and B) percentage of non-viable attached 
cells for E. coli interacting with gold, or gold that already had CP1-cys adsorbed.  After a 
20 min rinse with PBS, crystals were removed from the QCM-D, and bacteria were 
stained with Syto 9 and propidium iodide to quantify bacterial retention and viability. 
Stars represent significant differences between bacteria interacting with CP1-cys versus 
bacteria interacting with bare gold (P<0.05).   Bars to the right of solid black line 
represent strains expressing the O-antigen. 
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Figure 4.31 Comparing A) whole-cell binding and B) percentage of non-viable attached 
cells for E. coli interacting with silicon nitride, or silicon nitride that already had CP1 
adsorbed.  After a 20 min rinse with PBS, crystals were removed from the QCM-D, and 
bacteria were stained with Syto 9 and propidium iodide to quantify bacterial retention and 
viability. Stars represent significant differences between bacteria interacting with CP1 
versus bacteria interacting with bare silicon nitride (P<0.05).   Bars to the right of solid 
black line represent strains expressing the O-antigen. 
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4.4.8 Correlation between LPS Length and Cellular Viability on CP1-cys 
 Using the steric modeling, a comparison could be made based on LPS length and 
bacterial viability.  LPS length of O-antigen expressing strains were correlated using a 
Gaussian fit to bacterial viability, which was determined using the dual-staining 
technique (R
2
=0.86; Figure 4.32).  A different pattern was observed for control strains 
that do not express the O-antigen and were not included in the model.  Bacteria were 
most susceptible to CP1-cys with LPS lengths of 29 nm.  By subtracting the averaged 
LPS length of control strains that do not express the O-antigen, which is equal to 3.5 nm, 
the optimal O-antigen length for CP1-cys to inhibit bacterial viability is 25.5 nm.  The 
correlation was independent of O-antigen composition. Once the O-antigen reaches >54 
nm, the effect of CP1-cys would be negligible.  
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Figure 4.32 Correlating E. coli LPS length to E. coli viability as monitored with 
fluorescence microscopy using syto 9 and propidium iodide.   O-antigen expressing 
bacteria were analyzed using a Gaussian fit of whole cell viability versus equilibrium 
length. 
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4.4.9 Interfacial Free Energy 
  Interfacial free energy calculations for the 13 strains with bare gold, CP1-cys 
gold, silicon nitride, and CP1 silicon nitride and indicated that the nonspecific 
interactions measured by this test did not correlate well with AFM retraction forces.  The 
interfacial free energy calculations measured for each condition.  Strains O26:K60:H11, 
O55:H7, O113:H4, and O157:H16 are predicted to adhere better to CP1 coated silicon 
nitride and CP1-cys coated gold versus bare surfaces.  Strains K12, ML35, O113:H4, 
O157:H7, and O157:H12 preferentially bound to CP1-cys gold and O35:H10, 
O117:K98:H4, and O172:H- showed stronger adhesion to CP1 silicon nitride.  Only 
strain HB101 is predicted to bind stronger to both bare surfaces (Figure 4.33).   
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Figure 4.33 Interfacial Free Energy Calculations of 13 E. coli Strains on Silicon Nitride 
and Gold Substrates 
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 The IFE calculation results do not correspond well with retraction force curve 
results (Figures 4.34 & 4.35).  The linear regression value for bare silicon nitride is 
R
2
=0.11 and R
2
=0.25 for CP1 silicon nitride.  The trends were opposite as might have 
been expected, which indicate that non-specific interactions for which IFE calculates do 
not predict the specific interactions between CP1 and E. coli
216
.  White and Wimley 
studied the free energies that can be transferred from the water phase from the 20 amino 
acids and found that the amino acids interfacial free energies can be altered by unfolding 
events
274
.  With regards to the 31 amino acid chain CP1, by interacting with gold and 
silicon nitride that differ in terms of hydrophobicity (App H), we can therefore expect 
differing SFE calculations depending on the surface of deposition. 
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Figure 4.34 Interfacial Free Energy Calculations Compared to Retraction Forces 
Measured with Silicon Nitride Probes 
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Figure 4.35 Interfacial Free Energy Calculations Compared to Retraction Forces 
Measured with CP1 Modified Probes 
 
4.4.10 Zeta Potential 
 Control strains were the most negatively charged at <-40 mV (Figure 4.36).  
There is no clear trend of zeta potentials versus LPS length for control strains.  However, 
when considering the relation of E. coli LPS length to zeta potential, we found a positive 
linear correlation (Figure 4.37; R
2
=0.81).  E. coli O113:H4, O157:H16, and 
O26:K60:H11, which had the shortest LPS length, were comparable in terms of their zeta 
potentials.  E. coli with equilibrium polymer lengths ≥30 nm were the only strains with 
zeta potentials >-15 mV (Figure 4.37).  Strain O35:H10 was the only strains with LPS 
length >30 that had zeta potentials <-15 mV.  Zeta potential was independent of O-
antigen or core oligosaccharide composition.         
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Figure 4.36 Zeta Potentials for the 13 E. coli Strains Measured in Water 
 
 The zeta potential results are consistent with the IFE calculations in that the 
retraction force curve analysis did not correlate well in a linear regression; R
2
=0.31 with 
bare silicon nitride and R
2
=0.41 for CP1 silicon nitride (Figure 4.38 & 4.39).  The 
greatest outlier was O157:H7, however, omitting this bacterium causes no appreciable 
difference in linear regression.  Grouping all strains together, we found a positive linear 
correlation between LPS length and zeta potential (R
2
=0.81).  Zeta potential was not 
directly related to the nature of the O-antigen, and varied, for example, among strains of 
the O113 or O157 group. 
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Figure 4.37 Zeta Potentials Correlated with Equilibrium LPS Length 
Absolute Adhesion Force (nN)
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Figure 4.38 Zeta Potentials for the 13 E. coli Strains Correlated with Retraction Forces 
Measured with Silicon Nitride Probes 
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Figure 4.39 Zeta Potentials for the 13 E. coli Strains Compared to Retraction Forces 
Measured with CP1 Modified Probes 
 
 
 The electrostatic potentials of peptide solutions were measured to understand the 
role charge plays in peptide interaction with E. coli.  CP1 and CP1-cys solutions had zeta 
potentials of 17.6 ± 3.2 mV and 18.2 ± 2.7 mV.  
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5: Discussion 
5.1: Studying Protein Adsorption with QCM-D and AFM 
 When changing the liquid media from PBS to FBS, viscosity and density changes 
contributed to shifts in the frequency and dissipation.  The magnitude of the viscosity 
change can be calculated via dissipation monitoring
167, 168
.  A rinsing procedure of PBS is 
therefore necessary to remove loosely deposited FBS and to change the viscosity of the 
bulk liquid back to that of PBS.  A discrepancy between thicknesses obtained from 
QCM-D and AFM was seen for the protein-free system.    Since the underlying quartz 
crystal is not perfectly smooth, AFM section analysis resulted in a nonzero thickness, 
even though only PBS was introduced to the chamber. 
 The variability in the data was greater for AFM measurements than QCM-D 
modeling, which is mainly due to the small region of the quartz that could be sampled in 
a single AFM image.  The number of molecules that can be sampled in the solution and 
flow system of the QCM-D is much greater, and therefore the resulting thickness 
calculations show less variability. 
 Since researchers use both air and liquid measurements for AFM thickness 
calculations, we also compared the air thickness measurements with those from the 
QCM-D. In air, the thickness measurements did not agree with the AFM liquid or QCM-
D results.  The topography of the samples was  noticeably different, which we attribute to 
crystallization of the PBS and aggregation of the protein following drying
275
.  The 
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crystalline features on the 0% FBS crystal were not found in the cases with FBS 
deposition and were clearly FBS deposits. 
 Although researchers are interested in both techniques, this is the first study to 
demonstrate that QCM-D and AFM thickness measurements yield the same result for the 
case of determining protein layer thicknesses.  We also demonstrated that the Voigt 
viscoelastic model is appropriate to calculate the thickness of adsorbed protein layers. 
The advantages of using QCM-D are that it represents a faster way to obtain reliable 
thickness measurements, highly concentrated solutions can be studied, and it does not 
suffer from artifacts due to the drying process sometimes used for AFM imaging.  
Although not our focus, QCM-D can also be very useful for determination of kinetic 
properties of protein adsorption.  Advantages of the AFM are that very dilute solutions 
and single molecules can be observed. These two techniques can provide powerful and 
complementary information on protein and biomolecule adsorption. 
5.2: Enhancing Adsorption of CP1-cys to Gold 
 The adhesion of CP1 used to adsorb to silicon nitride was the same 31 amino 
chain peptide found in nature.  To enhance adsorption to gold, a thiol-gold bond was 
enabled by inserting an N-terminal cysteine group
276-278
.  There are, however, other 
means for the peptide to adsorb to gold, which include the many cationic regions on the 
peptide, amine groups
279-281
, and lysines
282
.  For these reasons, we experimented with 
numerous additives such as Tris(2-carboxyethyl)phosphine (TCEP)
283-285
 and 
trifluorethanol (TFE)
286-289
, adjusting the pH to neutralize the cationic regions and 
concentration to alter peptide orientation and enhance surface density.    
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 At neutral pH, CP1-cys binding affinity to gold was enhanced by 55% versus CP1 
to gold or silicon nitride.  While our results demonstrated that the cysteine residure at the 
C-terminal was effective, Uzarksi et al. discovered that the reducing agent TCEP can 
double the amount of peptide adsorbing to gold quartz crystal
256
.  Our findings suggest 
that CP1-cys adsorbs ~50% better to gold quartz crystals in the presence of TCEP versus 
the case of TFE or no additive, based on film thickness calculations.  Scenarios where the 
pH was raised to 9.2 resulted in minor decreases in peptide adsorption, which indicates 
the charged lysine residues had a minor role in peptide adsorption at neutral pH.     
 TCEP operates by cleaving disulfide bonds and is safer to use than other similar 
agents such as DTT and β-mercaptoethanol283.  In addition, TCEP is thiol-free, which 
makes it more advantageous to use over DTT.  Since TCEP does not adsorb through a 
mechanism as strong as a gold-thiol bond, it is conceivable that CP1-cys would be able to 
compete effectively in an environment containing a mixture of the two agents.  
Additionally, TCEP is a reducing agent, and therefore enhances peptide hybridization
290
.  
This may have further enhanced peptide orientation that assisted greater amounts of 
peptide to adsorb to gold and could impact the peptide‟s ability to adhere to bacteria291, 
292
.  Uzarksi et al. found regardless of additives, CP1-cys layed flat along a gold 
substrate.  However, with the addition of TCEP, the density of the CP1-cys adhering to 
the gold was doubled when compared to experiments without chemical additives
256
.  
Other product information regarding the enhancements of TCEP to peptides and proteins 
can be found from Uptima, Inc
283
.   
 TFE is a strong hydrogen donor and the concentrations used in the current study 
were far greater than that of TCEP
293
.  Kypr et al. suggest using aqueous concentrations 
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as high as 60-80% TFE to mimic the physiological conditions of crystalline DNA
294
.  
TFE reduces hydrophobic-hydrophobic interactions, which can enhance the alpha helical 
form of the peptide
295, 296
.  However, despite potential enhancements in peptide 
orientation, our results show that preventing disulfide bonding does not have significant 
impact on CP1-cys adsorption.   
5.3: Bacterial Adhesion + Properties of LPS 
5.3.1 Steric Modeling of Control Strains 
 While the LPS lengths of the control strains should be approximately the same, 
differences in adhesion with silicon nitride were observed.  These differences may have 
been due to length differences and the presence of other biomacromolecules on the 
surfaces.  Normally, the O-antigen masks underlying proteins in the outer membrane. 
However, since the control strains lack the O-antigen, Fadh that we observed may also 
have been related to the lipid A and other biomacromolecules.  For strains HB101, K12, 
and ML35, the calculated LPS length is due to the combination of the core 
polysaccharide and lipid A.   
 Steric modeling resulted in a calculated LPS length that is consistent with the 
findings of Lee et al. and Pangburn.  Lee et al. estimated the lipid A region to be ~2.3 nm 
297
, with the length due to fatty acids of C12, C14, C16, and C18 
298
.  The length of a 
single O-antigen unit was estimated to be ~1.0 to 1.3 nm 
76, 299
.   The combination of the 
lipid A plus inner, and outer cores was 4.4 nm for E. coli and Salmonella typhimurium 
299
.  Our control strains had LPS lengths estimated close to these values.     
 We sometimes calculated shorter LPS lengths with our steric model than might be 
expected from the literature for control strains.  Although our prior work has shown that 
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steric repulsion dominates bacterial AFM approach curves, electrostatic interactions can 
also influence LPS conformation
232, 272
.  Lower ionic strength solutions correlate to 
increased steric repulsion
300
.  For example, an ionic strength increase from 0.01 M to 0.1 
M reduced bacterial polymer length 4-fold due to coiling of bacterial surface molecules 
232
.  At the ionic strengths used in the present study, the reported LPS length values may 
also reflect the coiling of biopolymers on the bacterial surface.  However, the same ionic 
strength was used for all experiments, so this coiling effect would have been constant for 
all strains. 
 Since the adhesion forces were not the same for the three control strains, we 
looked for other factors (besides LPS) that would have caused different adhesion forces.  
ML35 produces the enzyme β-galactosidase, which acts as a phenotype marker301.  ML35 
releases larger quantities of β-galactosidase following membrane penetration301.  The 
presence of β-galactosidase may have enhanced adhesion with the silicon nitride probe, 
although this would need to be confirmed with other experiments. 
5.3.2 Steric Modeling of O-antigen Expressing Strains (O157 & O113) 
 Bacteria are classified in terms of repeating chains of their O-antigen, capsular 
composition, and flagella antigens
65
, but the number of repeating O-antigen units is not 
part of the serotype classification and may vary greatly within a population of bacteria.   
E. coli equilibrium LPS lengths were 
O113:H21>O157:H7>O157:H12>O157:H16>O113:H4 for strains that have O-antigens 
identical to at least one other strain.    The O157 strains did not significantly differ from 
one another in terms of average adhesion forces with silicon nitride.  E. coli O113:H21 
was significantly more adhesive to silicon nitride than all other strains (P<0.05).   
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 The O-antigen is a highly variable structure that enables E. coli attachment to a 
host cell or biomaterial using specific ligand-receptor bonding.  For instance, E. coli 
O113 and O157 can adhere well to the intestinal tract and fresh produce
64
.   
 Our results suggest differing sections of the LPS mediated adhesion to silicon 
nitride for control and O-antigen expressing strains.  With the exception of O113:H21, 
Fadh was the same for control and O-antigen expressing strains.  However, Fadh was 
independent of core length for control strains, while an increasing number of O-antigen 
units present caused Fadh to increase.  Underlying proteins and lipids may have adhered to 
the silicon nitride probe in the case of the control strains
302
.  Even the shortest calculated 
O-antigen of 13 nm for O113:H4 (calculated by subtracting LPS length of O113:H4 with 
averaged LPS length of control strains) may have blocked the effects of underlying 
proteins and lipids.  LPS binding may have been governed by the number of O-antigen 
units interacting with the silicon nitride.  The O-antigen of O113:H4 may be too short to 
adhere as well to silicon nitride as O113:H21. Murray et al found 16 to 35 units of the O-
antigen expressed by Salmonella enterica to be most efficient for macrophage cells to 
adhere to and uptake bacteria
76
.   This study found a similar trend in that ~15-35 units of 
the O-antigen on average was most efficient for E. coli adhesion to silicon nitride.  
However, based on force cycle analysis, longer O-antigens extending >60 nm had the 
strongest Fadh.      
 E. coli O113 is an enterohaemorrhagic strain (EHEC) due to expression of Shiga-
like toxins
303
.  Adhesion to host cells in the intestinal tract is a precondition to symptoms 
of dysentery
96, 304
.  Whether LPS length, which correlates well to Fadh in the present 
study, can predict E. coli virulence could be the basis for further study.   
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5.3.3 Steric Modeling of Remaining Strains 
 Strains O35:H10, O117:K98:H4, and O172:H- adhered significantly better to 
silicon nitride than the control strains.  Strain O55:H7 was comparable to the control 
strains and O26:K60:H11 was significantly less adhesive.  Strains O172:H- and 
O117:K98:H4 are enterohaemorrhagic E. coli (EHEC), while O55:H7 and O26:K60:H11 
are EHEC and Enteropathogenic E. coli (EPEC). Intimins, which are outer membrane 
proteins of E. coli, determine whether strains are EPEC or EHEC strains
90
.  For instance, 
α intimin is associated with EPEC and intimins ε and γ are associated with EHEC.  The β 
intimin is found in strains that are both EHEC and EPEC, such as the O26 serotype
89
.  
The AFM probe did not adhere to the intimins because intimins specifically target 
receptors of epithelial cells
305
.   
 The estimated O-antigen lengths for strains O26:K60:H11, O35:H10, 
O117:K98:H4, O55:H7, and O172:H- are 15 nm, 38 nm, 40 nm, 37 nm, and 41 nm, 
respectively.  The adhesion forces did not correlate well to O-antigen lengths in this 
group.  E. coli O26:K60:H11, having the shortest LPS, had the weakest adhesion forces, 
while O55:H7 was comparable to the control strains in terms of attraction force, but the 
LPS length was significantly longer (P<0.05).  Surface free energy calculation may be 
more appropriate for correlating E. coli adhesion to abiotic surfaces than LPS 
composition because non-specific forces govern adhesion of LPS to silicon nitride
178
.          
 The literature to this point has focused namely on the genetic traits necessary for 
creating the O-antigen, while spending little time investigating the purpose of the O-
antigen.  Russo et al. found that deleting the O4 antigen from E. coli CP9.137 and CP922 
has a minor role in the level of  virulence in serum
306
.  In contradiction, Merino et al. 
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found that the O-antigen O34 was necessary for Aeromonas hydrophila to adhere to the 
chicken gut
307
.  At temperatures below 20°C, the bacteria expressed the O-antigen, while 
at 37°C the bacteria no longer expressed the O-antigen and hence could no longer 
colonize the chicken gut.  Salmonella enterica, which is a major food contaminant, was 
also found to require the O-antigen to express virulence in eggs
308
.      
5.3.4 Comparing O-antigen Composition to Fadh 
 The profile of exponentially increasing adhesion forces to longer LPS indicates 
that more sugars of the O-antigen chain were binding to the silicon nitride.  Comparing 
adhesion profiles (Figure 4.28 & Table 4.5), O113 appears to operate more efficiently 
with fewer O-antigen units than O157.  The O157 O-antigen is comprised of the sugars 
rhamnose, fucose, glucose, and galactose, while each chain unit for O113 contains four 
galactose sugars and one glucose (App E).  Galactose is a necessary carbohydrate for 
binding to proteins such as galectins
309
.  Glucose has also been found to metabolically 
enhance bacterial adhesion.  Staphylococcus epidermidis grown in the presence of 
glucose has been found to adhere strongly to plastic, while strains grown in TSB 
neglecting glucose were unable to attach
310
.  However, the effects of glucose on binding 
to biomolecules in the O-antigen have no been investigated.  The sugars Fucose
311
 and 
rhamnose
312
 are necessary for mediating O-antigen adhesion to biomolecules.  From our 
force analysis, galactose may also be necessary for strong adhesion to silicon nitride 
probes, while glucose is also necessary for adhesion.  The combination of the 4 sugars, 
however, appears to not be as efficient for binding to silicon nitride as O-antigen 
comprised of 80% galactose based sugars.     
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 The complexities regarding the number of O-antigen units make identifying the 
mechanism for these differences is a daunting task.  For example, E. coli O35:H10 
contains multiple αLRha sugar groups, while O117:K98:H4 contains one unit in the O-
antigen. The αLRha sugar could be responsible for the greater adhesion ability to silicon 
nitride, however, O26:K60:H11, which also contains the αLRha sugar was statistically 
less adhesive than the control strains, and with strains O35:H10 and O26:K60:H11 
(P<0.05).    
5.3.5 Effect of Core Type on Fadh 
 The core oligosaccharide serves as bridge between the highly variable O-antigen 
and lipid A.  There are only 5 core groups for E. coli; K12, R1, R2, R3, and R4.  The O-
antigen is not conserved to particular core oligosaccharides.  For instance, O113:H4 has 
the R3 core and O113:H21 R1 core.  E. coli O117 serotype has been reported to have the 
K12 core oligosaccharide and the R1 core
1
.  Similarly O157:H7 has an R3 core, while 
O157:H12 and O157:H16 have the R2 core.  The R2 and K12 cores share backbones, 
with differences found in the terminal side chains
313
.  Bacterial cores serve as 
intermediaries between O-antigen and lipid A and whether the core is actively involved 
in bacterial adhesion is unknown.        
 The core oligosaccharide had little influence over core length or attraction force. 
For example, the R3 core incorporates O113:H4 and O157:H7.  Strains O157:H12 and 
O157:H16 had R2 cores and the core lengths were nearly identical.  Strain O113:21 had 
the R1 core, which behaved very differently from O113:H4 in terms of adhesion force.  
The R1 core dominates the O113 serotype, which signifies an adaptive advantage for the 
R1 core type over R3 in O113
1
.  Because adhesion forces were so different between 
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O113:H4 and O113:H21 it appears the core group of the LPS has a pivotal role for 
selecting which materials the bacterium can adhere to. 
5.4: Peptide-E. coli Interactions 
 
5.4.1 Non-specific and Covalent Bonding of Cecropin P1 to Silicon Nitride and Gold 
 For CP1 adsorbing to silicon nitride, the dissipation reached a maximum of 6.0 x 
10
-7
 and a final value of 5.0 x 10
-7
, which was a sixth of what we observed with CP1-cys 
adsorbing to gold.  While the quantity of adsorbed mass could explain discrepancies 
between dissipation values, the frequency change response was only twice as much for 
CP1-cys.  Thus in addition to changes in the amount of adsorbed mass, the way that the 
peptide adsorbed to gold  or silicon nitride apparently were through different orientations 
of the peptide on the surface.      
 When CP1 was introduced to the gold quartz crystal, peptide immediately 
adsorbed, as could be seen by the rapid drop in frequency change.  However, the change 
in dissipation was slower to respond.  This indicates that initially peptide adsorbed in a 
rigid fashion, possibly in a conformation parallel to the gold surface.  As more CP1 was 
added, the frequency change began to drop more slowly, indicating that the rate of 
adsorption decreased.  However, dissipation continued to increase to a maximum 
dissipation of 6 x 10
-7
.  We considered that this might be due to the formation of 
multilayers, since CP1 that formed multilayers would be more viscous than a peptide 
monolayer.  At higher peptide concentrations than used in this study, alpha-helical 
peptides can form multilayers
314
.  However, formation of multilayers would result in 
significant drops in frequency due to the added mass, which we did not observe. 
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Therefore discrepancies in dissipation response of CP1 on gold and silicon nitride were 
due to peptide standing more vertically on gold than silicon nitride.    
 We think that CP1 may adsorb differently on gold and silicon nitride, even though 
both types of binding are non-specific.  The local properties of each substrata may be 
responsible for binding with different orientations.  Differences in peptide orientation and 
adsorption to polystyrene and silica have been observed to be dependent on local surface 
hydrophobicity
315
.  Increases in dissipation changes, such as what we observed for CP1 
on gold, indicate changes in peptide orientation to a slightly more upright position
316
.  
This may have occurred as CP1 already adsorbed prevented additional mass of CP1 to 
orientate and adsorb in a parallel orientation to the gold.  When PBS was rinsed over the 
crystal surface, the loosely deposited peptide was removed and the remaining CP1 was 
parallel to the gold crystal, which is consistent with the dissipation change dropping by 
~2.0 x 10
-7
 during the rinse phase.   
 The PBS rinse did not remove as much CP1 on silicon nitride compared to CP1 
on gold, which would be consistent with a more firmly attached rigid peptide layer, 
possibly due to strong hydrogen bonding with silanol groups.  CP1 may bind without 
specific orientation using hydrogen bonds to silanol groups on silica
317, 318
, which coats 
the silicon nitride when oxidized.  In addition, hydrophobic regions of peptides can align 
with hydrophobic residues on silica
315
.  Our water contact angle of silicon nitride of 54° 
supports the presumption that the hydrophobic side of the peptide was facing the 
substratum. 
 CP1-cys adsorbed ~55% more to gold than CP1 adsorbed to either silicon nitride 
or gold based on areal mass calculations.  It also appears that the peptide conformation 
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changed, depending on the surface that CP1 or CP1-cys was adsorbing to.  Our 
dissipation data reveals a significantly more rigid peptide film for CP1 on silicon nitride, 
compared with CP1-cys on gold.  The maximum dissipation change achieved for CP1-
cys adsorbing to gold was between ~3.0 x 10
-6
 and ~2.8 x 10
-6
, depending on the 
harmonic, and the frequency and dissipation changes data mirrored each other.   
 CP1-cys on gold may have been in a more upright orientation, as peptide that 
retained on the surface had a dissipation of 2.8 x 10
-6
.
 
 Peptide standing upright and 
attached to a substrata in with a single covalent bond will be more viscous than peptide 
laying parallel to a surface and attached to the substrate in multiple points.  While 
standing more upright than CP1, CP1-cys may still not have been in a perfectly ordered 
film.  Previous work showed that addition of the reducing agent tris(2-
carboxyethyl)phosphine (TCEP) helped CP1-cys form a more ordered peptide film on 
gold
256
.  The use of reducing agents was not tested in the present study.   
5.4.2 Binding Between E. coli and Antimicrobial Peptides (AMPs) 
 By enhancing the understanding of the mechanism by which AMPs interact with 
bacterial LPS, more potent AMPs can be designed.  CP1 is a model antimicrobial peptide 
that has demonstrated strong binding to pathogenic E. coli, such as O157:H7
143
.  Our 
goals were to characterize which features of bacterial LPS enhance selectivity and 
antimicrobial activity of CP1, and to determine if bound CP1 maintains antimicrobial 
properties. 
 While the antimicrobial activity of CP1 in solution has been documented
319, 320
, 
the ability of a bound peptide to inactivate bacteria has not been proven.  Our results 
show that peptide physisorbed to silicon nitride was antimicrobial against pathogenic E. 
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coli, but had only moderate activity against E. coli when CP1-cys was covalently bound 
to gold.  The bond between CP1-cys and gold apparently decreased the mobility of the 
peptide, and therefore CP1-cys had less ability to penetrate the bacterial membrane.  
 While interactions of antimicrobial peptides with bacterial phospholipids have 
been well studied
125, 286, 288, 321
, there have been few studies of AMP interactions with the 
O-antigen region of the LPS, even though peptides must pass through the O-antigen 
before interacting with the underlying phospholipids
302, 322
.   
 In our work, non-specific forces such as hydrophobic interactions and hydrogen 
bonding appeared to govern the initial adhesion of CP1 to the O-antigen region of the E. 
coli LPS.  Electrostatic interactions played a lesser role for interaction with the E. coli O-
antigen.  The chemical structure of the O-antigen was not dominant, since Fadh and the 
number of bacteria that attached to a CP1-coated substrate varied significantly among E. 
coli strains with identical O-antigens, and a trend could not be seen with regard to the 
type of sugar in the LPS O-antigen and either adhesion forces or attachment.  In a 
previous study that did not involve antimicrobial peptides, showed that the chemical 
nature of the O-antigen did not control adhesion forces with clean silicon nitride
273
. 
 Hydrogen bonding could explain the nonspecific interactions that we observed 
between O-antigen and peptide.  While we could not directly measure hydrogen binding 
between the O-antigen and peptide, Jucker et al. found hydrogen bonding is an important 
function of the O-antigen that initiates adhesion to biomolecules and minerals
302
.  
Additionally, hydrophobic helical hexadecapeptides will bind to self-assembled 
monolayers terminated with carboxyl groups
323
, which may also be a mechanism for 
peptide binding with the O-antigen.   E. coli expressing the O-antigen have good 
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correlations between Fadh of silicon nitride and O-antigen length, which was associated 
with increased hydrogen bonding
273
.  While we could not measure Fadh with CP1 and 
correlate with LPS length per force cycle due to limitations of the steric model, we 
observed stronger Fadh with CP1 with the overall LPS length of the bacterium (Figure 
4.27).     
 In addition to hydrogen bonding, hydrophobic interactions may have also played a 
large part in the interaction force between peptide and O-antigen.  In our AFM 
experiments, the orientation of CP1 on the tip was partially controlled by hydrophobic 
interactions
315
.  The water contact angles for silicon nitride and gold were 54° ± 2 and 
63° ± 1, respectively.  If the hydrophobic section of the peptide was facing the silicon 
nitride substrate, then the O-antigen was seeing the hydrophilic portion of the peptide.  
Control strains and bacteria with shorter O-antigens would have had their hydrophobic 
lipid A exposed, which may have hindered both whole cell binding and reduced adhesion 
with the exposed hydrophilic regions of peptide, since previous studies showed that 
hydrophobicity controlled adhesion to minerals
324
 and aggregation of LPS is driven by 
hydrophobic forces
325
.  We observed that Fadh with CP1 increased exponentially as O-
antigen length increased, possibly due to peptide interacting with the more hydrophilic O-
antigen
326
.   
 The N-terminal region of CP1 is highly charged and may be attracted to the O-
antigen, which can be neutral or  negatively charged under physiological conditions
327
.  
From zeta potentials of peptide in PBS, we know under experimental conditions the 
peptide retained a cationic charge.  However, electrostatic interactions do not appear to 
dominate the binding forces or attachment between the bacterial strains and CP1, since 
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trends observed between bacterial zeta potentials and either attachment of bacteria to a 
CP1 surface, or adhesion forces between bacteria and the CP1 were opposite than would 
be expected (Figures 4.37-39).  Whole cell binding data followed a similar trend between 
Fadh with CP1 and LPS length.  Bacterial retention was greater to cys-CP1 compared to 
CP1 and peptide laden substrata all had greater or equal numbers of bacteria than for 
substrata not coated with peptides.  We even observed greater whole-cell binding of 
control strains with peptide, despite hydrophobic interactions being unfavorable.  
However, electrostatic interactions with the negatively charged phospholipids may have 
been significant enough to enhance bacterial retention.    
5.4.3 Nature of O-antigen on Influencing Bacterial Binding with Cecropin P1 
 Fadh between E. coli and the CP1 coated AFM tip did not show any systematic 
trend in terms of O-antigen composition.  Instead, O-antigen length appears to be a 
significantly more important factor based on correlations of Fadh and LPS length.  For 
example, Fadh was significantly different among strains expressing the O157 strains and 
O113 O-antigens (P<0.05).   Even when comparing bacteria with different O-antigens, 
there was a strong correlation between LPS length and Fadh.   
 Bacterial attachment studies also showed that E. coli expressing longer LPS were 
better retained to the quartz crystals.  O-antigen compositions were poor predictors of 
whether E. coli would preferentially bind to peptide.  For example, of O113 strains, only 
E. coli O113:H21 preferentially bound to CP1.  Whether it be CP1 or CP1-cys, E. coli 
O157:H7 bound to peptide > than O157:H12, which was > than O157:H16.  This also 
correlates to the calculated LPS length, where O157:H7 is estimated to have LPS of 30 
nm, O157:H12 is estimated to be 25 nm, and O157:H16 is estimated to be 19 nm.        
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 These findings suggest nonspecific interactions are occurring such as hydrogen 
bonding between the O-antigen and CP1.  A study by Jucker et al. also found that no 
correlation between isolated O-antigen composition and binding to minerals such as SiO2 
exists
328
.  Hydrogen bonding has been found to play an important role for the O-antigen 
and no study has explored binding between AMPs and O-antigens.  The results of the 
current study demonstrate that non-specific hydrophobic/electrostatic interactions 
governed binding between peptide and O-antigen.         
5.4.4 Relation between Bacterial Viability and Method of Peptide Adsorption 
 All 13 strains were susceptible to killing when exposed to physisorbed CP1 on 
silicon nitride, whereas only four strains lost viability when exposed to CP1-cys on gold.  
One model of how antimicrobial peptides inactivate bacteria suggests that the peptide 
molecule needs to orient itself such that the hydrophobic end is towards the lipids and the 
hydrophilic section is closer to the phospholipids
140.  According to this “carpet model”, 
the bacterial membrane eventually disintegrates due to alterations in the membrane 
curvature
141
.  This model may explain why bound CP1-cys could not kill the bacteria as 
well as the physisorbed CP1, since the thiol bond prevented the peptide from freely 
changing orientation.  However, another model suggests that peptides can be taken up by 
bacteria from a perpendicular orientation to the bacterial membrane, which is called the 
barrel stave model
329
.  By forming pores in the bacterial membrane, this would make it 
easier for the peptide to lyse bacteria, even in the presence of the thiol bond. 
5.4.5 Interfacial Free Energy; Modeling E. coli Binding with Peptide 
 Fattal and Ben-Shaul developed a model for calculating interfacial free energy 
between lipids and proteins that may be applicable to the current study
330
; however,  the 
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current study focuses namely on polysaccharide-peptide interactions and neglects the 
effects of the lipid A.  Indeed, multiple studies have explored peptide-lipid interactions 
and have found favorable interactions to exist
331-334
, however, none have explored whole 
cells interacting with peptides.  Lipid-peptide interactions are favorable, but none have 
incorporated the O-antigen or core polysaccharide to study whether the peptide-bacterial 
interaction is favorable. It is possible that several different mechanisms are necessary for 
peptides to interact favorably with the complexities of the bacterial LPS such as 
electrostatic interactions, hydrophobic interactions, and ligand-receptor bonding.  Our 
results suggest that the O-antigen requires hydorgen bonding with the bacterial LPS, and 
then the peptide may pass through the lipid-A region and interact with the hydrophobic 
domains to disrupt the cellular membrane. 
5.4.6 Relation between LPS Length and Electronegativity 
 Our zeta potential results are consistent with the findings from the literature in 
which E. coli O157:H7 has zeta potentials ranging from -4.0 to -19.7 mV
335, 336
.  Zeta 
potentials among similar serotypes vary widely, as is evident among the O157:H7 
serotype.  The range of zeta potentials calculated in the present study are consistent for E. 
coli
337, 338
.  However, E. coli zeta potentials did not correlate as expected since more 
negatively charged E. coli had lower Fadh whole cell binding to peptide.    
 Zeta potential is partially determined by the negatively charged phospholipids.  
The lipid region of the LPS was considered to have a conserved length among all strains 
since differences in chain lengths from C10 to C16 are in the range of Angstroms.   LPS 
length is highly dependent on the numbers of O-antigen repeating units
76
 and since these 
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units are neutrally charged or slightly negatively charged , they did not contribute greatly 
to observed zeta potentials
327
.  
 When all bacterial zeta potentials are correlated to LPS length, an inverse relation 
was found.  This was unexpected since electrostatic interactions are considered very 
important for AMPs to target bacteria
339, 340
.  Indeed, control strains had the lowest zeta 
potential <-40 mV, while O-antigen expressing strains had zeta potentials >-30 mV.  
Further, zeta potentials of peptide solution were found to be 18 mV, which favor 
interaction with the more negatively charged E. coli.  The correlation of LPS length 
versus zeta potential demonstrates that the O-antigen region may be shielding the 
electrostatic double-layer from being detected by the zeta potential analyzer (Figure 
4.37).  E. coli O157:H7 had a particularly long LPS and may have masked some of the 
negatively charged phospholipids, whereas the control strains that did not express O-
antigen were found to have the lowest Zeta potential.  
 The zeta potentials for control strains were significantly greater than that of all 
other strains.  There are few differences between strains.  E. coli ML35 produces β-
galactosidase from the lac operon
341
 and the 1171 amino acids
342
 give this molecule an 
isoelectric point (PI) at pH 4.2
343
.  At pH 7.2-7.4, which zeta potentials were measured at, 
β-galactosidase will have a net negative charge and may have contributed to zeta 
potentials being significantly lower than other strains.   
 Truncated LPS have been reported to be associated with more electronegative 
cells.  Razatos et al. found E. coli D21 to have a zeta potential of -29 mV, while zeta 
potentials for E. coli D2e19, D21f1, D21f2, which had truncated LPS, had zeta potentials 
>-40 mV
344, 345
.    According to Walker et al., the O-antigen may block underlying lipids 
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and phospholipids from being detected
346
.  Walker et al. found the O-antigen expressing 
strain had a zeta potential >-35 mV, while E. coli only expressing the core polysaccharide 
had zeta potential of <-60 mV.  In the present study, we quantified the LPS length of 13 
E. coli strains and found a strong correlation between longer O-antigens and less 
electronegativity.      
 While charge is clearly important for AMPs to lyse bacteria based on proposed 
carpet model and cationic charge of peptides, the initial interaction between pathogenic 
E. coli  and peptides may be not be driven by electrostatic forces.  Our AFM and whole 
cell binding results demonstrate strongest attraction of peptide with O-antigen expressing 
bacteria, which were least electronegative.  Although E. coli with truncated LPS were 
most electronegative, Fadh with peptide was lower compared to O-antigen strains, and this 
observation was more evident with whole cell binding to CP1-cys.  The O-antigen length 
appears to dictate the quantity of hydrogen bonds with peptide, extent of hydrophobic 
interaction, and limits the electrostatic interactions with peptide.    
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6: Conclusions 
 This study was comprised of 3 phases that included: 
1. Studying the LPS and O-antigen for 10 E. coli strains and comparing features such as 
LPS length and force data with 3 control strains that lack the O-antigen.  AFM approach 
curves were a measurement of steric hindrance of the bacteria, which were useful for 
calculating surface properties of E. coli such as LPS polymer length.  In addition, AFM 
pull-off forces enabled us to measure which O-antigens adhered better to silicon nitride 
and we could measure the flexibility of the O-antigen. Zeta potentials and IFE 
calculations further enhanced our understanding of the surface features of the E. coli.   
2. Measuring the adsorption and retention of CP1 and CP1-cys to silicon nitride and gold 
substrates, respectively, to determine peptide density, film thickness, and orientation on 
the substrates.  We accomplished CP1 and CP1-cys deposition analysis namely with the 
QCM-D Voigt Viscoelastic Modeling. 
3. Measuring the binding forces and quantifying whole cell binding of 13 E. coli strains 
to determine what features, such as SFE, charge, LPS length, and O-antigen composition, 
are important to promote E. coli adhesion to AMPs.  By coating the AFM silicon nitride 
probe with CP1, we measured binding forces between CP1 and the 13 E. coli strains.  
Summary of Main Results  
 With the steric hindrance data we found that the LPS length is pivotal for bacterial 
adhesion to occur with organic materials such as peptides and inorganic materials such as 
gold and silicon nitride.  O-antigen lengths >30 nm are optimal for promoting adhesion to 
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silicon nitride and CP1 silicon nitride.  Although the control strains adhered better to CP1 
than to bare silicon nitride, the differences in adhesion force were small and we associate 
this preference to electrostatic, hydrophobic interactions, and hydrogen bonding with the 
O-antigen region of the LPS.  Indeed, the LPS was calculated to be ~3-5 nm for the 
control strains and was useful for estimating the lengths of the O-antigens among the 
remaining E. coli.  In 10 of the 13 strains, including all of the O157 serotypes, adhesion 
to CP1 was significantly greater than compared to bare silicon nitride, which correlated 
well with LPS length. 
 Zeta potentials and IFE calculations did not correlate well with AFM adhesion 
measurements, which may suggest that specific interactions were being measured with 
the AFM.  Hydrophobic/electrostatic interactions cannot alone explain bacterial adhesion 
to peptide or metallic substrates.  We found evidence that O-antigen partially blocked the 
electrostatic double layer from being detected in the zeta potential measurements.   
 QCM-D Voigt Viscoelastic Modeling and AFM section analysis correlated well 
based on thickness calculations for the FBS deposition experiment.  Whether for 
characterizing protein or peptide films, the QCM-D modeling is superior compared to 
AFM because of the real-time analysis, no sample perturbation during the experimental 
phase, and availability of numerous substrates versus the limited available with AFM 
probes (usually silica or silicon nitride).   
 In the peptide adsorption studies, the QCM-D modeling showed that TCEP 
enhances CP1-cys adhesion by ~50% to gold on the basis of areal mass calculations.  
Increasing the pH to 9.2 moderately decreased peptide adsorption and TFE had no 
significant impact on peptide adsorption or orientation.    
 
 
Section 6                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
133 
 Although the results of this study demonstrate the potential of CP1 as a part of 
biosensor, our findings also reveal the mechanisms by which AMPs lyse bacteria.  Two 
distinct models have been developed to explain how peptides lyse bacteria called the 
„barrel stave model‟ and „carpet model‟, and both models neglect important details of 
cellular destruction.  This is the first study to quantitatively measure both E. coli LPS 
length and bacterial electronegativity.  Our findings show bacteria with longer LPS 
(pathogenic E. coli strains) being less electronegative, which would seem unfavorable for 
interaction with AMPs that are cationic.  Because of this unexpected relation, we 
concluded that hydrophobic interactions are dominant during the initial interaction 
between CP1 and E. coli.  While this does not necessarily mean the „barrel stave model‟ 
fully describes cellular lyses, we are able to gain insight on how the peptide bypasses the 
O-antigen, which both models have neglected.  Our findings will be useful in designing 
new peptides to lyse bacteria, which have been largely unsuccessful, partially because 
studies have only concentrated on peptide interaction with the cellular inner membrane.   
 This study was initially aimed at describing peptide interactions with E. coli based 
on their O-antigen compositions.  While O-antigen composition did not appear to dictate 
binding or deactivation of E. coli in contact with peptide, we made significant progress in 
understanding several key LPS qualities that do promote interaction with peptide.  The 
literature has very limited information regarding bacterial interactions with AMPs, and 
studying functionality of covalently immobilized peptide is a novel area of study.  We 
plan on expanding on the number of bacteria and peptides used to further investigate 
whether we can detect specific interactions between LPS and AMPs.  
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7: Future Work 
 The LPS is a complex and highly variable component of the bacterium.  If a more 
automated procedure for analyzing force curves can be devised, force mapping of the 
bacterial surface for hundreds of bacteria could yield significantly more information 
about the LPS length and binding forces.  Density calculations of the LPS can be 
measured in solutions of lower ionic strength such overlapping of the LPS molecules is 
prevented. 
 CP1 adhesion to the AFM probe may be enhanced by using a gold coated tip or 
using NHS to assist in CP1 adsorption
347
.  However, when modifying the methods for 
CP1 adsorption, it should be cautioned that chromium, commonly used as an under-layer 
for gold, can escape and affect bacterial viability
348
.  Additionally, ensuring that bacteria 
are not exposed to NHS immobilized on the AFM probe will be essential since the 
chemical is used in binding E. coli to glass.   
 Furthermore, obtaining more isolates from differing sources could better our 
understanding of the natural variability of E. coli within a serotype.  CP1 was selected for 
further study because of the results obtained from Mello and Soares
143
.  However, the 
numbers of peptides that exist and can be engineered are limitless.  Few studies have 
considered using peptides as biosensors and it may be beneficial to explore peptides that 
are known to destroy foreign invaders such as defensin
349, 350
, melittin
351
, aurein
352
, 
maximin
353
, and other  cecropins
354
.  Once comparative studies are conducted, we might 
be better positioned to cater a biosensor for detection of a particular serotype and further 
understand the role the O-antigen has in bacterial adhesion.   
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9: Appendices 
 
Appendix A: Ethanol Calibration Graphs 
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 Figure 9.1 50 μl per min ethanol flow rate 
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 Figure 9.2 100 μl per min ethanol flow rate 
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 Figure 9.3 150 μl per min ethanol flow rate 
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 Figure 9.4 200 μl per min ethanol flow rate 
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 Figure 9.5 400 μl per min ethanol flow rate 
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 Figure 9.6 50 μl per min ethanol flow rate 
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 Figure 9.7 100 μl per min ethanol flow rate 
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 Figure 9.8 150 μl per min ethanol flow rate 
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 Figure 9.9 200 μl per min ethanol flow rate 
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 Figure 9.10 400 μl per min ethanol flow rate 
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 Figure 9.11 50 μl per min ethanol flow rate 
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 Figure 9.12 100 μl per min ethanol flow rate 
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 Figure 9.13 150 μl per min ethanol flow rate 
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 Figure 9.14 200 μl per min ethanol flow rate 
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 Figure 9.15 400 μl per min ethanol flow rate 
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 Figure 9.16 50 μl per min ethanol flow rate  
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 Figure 9.17 100 μl per min ethanol flow rate 
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 Figure 9.18 150 μl per min ethanol flow rate 
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 Figure 9.19 200 μl per min ethanol flow rate  
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    Figure 9.20 400 μl per min ethanol flow rate  
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Appendix B: FBS Adsorption Graphs 
 
Time (hrs)
0 1 2 3 4 5
A
re
a
l 
M
a
s
s
 (
n
g
/c
m
2
)
0
500
1000
1500
2000
3rd Harmonic
5th Harmonic
7th Harmonic
9th Harmonic
Water
PBS
0.01% FBS
PBS (Rinse)
0.10% FBS
PBS (Rinse)
PBS (Rinse)
PBS (Rinse)
PBS (Rinse)
1.00% FBS
10.0% FBS
100% FBS
 
 Figure 9.21 Crystal 1 FBS Adsorption  
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 Figure 9.22 Crystal 1 FBS Adsorption 
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 Figure 9.23 Crystal 2 FBS Adsorption  
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 Figure 9.24 Crystal 3 FBS Adsorption  
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 Figure 9.25 Crystal 4 FBS Adsorption  
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Figure 9.26 Thickness modeling of parallel QCM-D experiments with FBS.  Results also 
analyzed with the AFM. 
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Figure 9.27 Areal mass calculations of parallel QCM-D experiments with FBS   
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Figure 9.28 FBS thickness modeling with the QCM-D.  Results also analyzed with the 
QCM-D 
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Appendix C: CP1-cys Adsorption to Gold and CP1 
Adsorption to Silicon Nitride 
 
 
 Figure 9.29 Silicon nitride 10 μM Neutral CP1 
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  Figure 9.30 Silicon nitride 10 μM Neutral CP1 
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 Figure 9.3110 μM Neutral CP1 
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 Figure 9.3210 μM Neutral CP1 
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 Figure 9.33 10 μM pH 9.2 CP1 
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 Figure 9.34 10 μM pH 9.2 CP1 
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Figure 9.35 29.1 μM neutral CP1 
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 Figure 9.36 29.1 μM neutral CP1 
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 Figure 9.37 29.1 μM pH 9.2 CP1 
Time (hrs)
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0
T
h
ic
k
n
e
s
s
 (
n
m
)
0
1
2
3
4
5
6
Crystal 1
Crystal 2
Crystal 3
Crystal 4
PB
C-P1
Rinse (PB)
 
 Figure 9.38 29.1 μM pH 9.2 CP1 
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 Figure 9.39 TCEP 10 μM neutral CP1 
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 Figure 9.40 TCEP 10 μM neutral CP1 
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 Figure 9.41 TCEP 10 μM pH 9.2 neutral CP1 
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 Figure 9.42 TCEP 10 μM pH 9.2 neutral CP1 
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 Figure 9.43 TCEP 29.1 μM neutral CP1 
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 Figure 9.44 TCEP 29.1 μM neutral CP1 
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 Figure 9.45 TCEP 29.1 μM pH 9.2 CP1 
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 Figure 9.46 TCEP 29.1 μM pH 9.2 CP1 
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 Figure 9.47 TFE 10 μM neutral CP1 
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 Figure 9.48 TFE 10 μM neutral CP1 
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 Figure 9.49 TFE 10 μM pH 9.2 CP1 
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 Figure 9.50 TFE 10 μM pH 9.2 CP1 
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 Figure 9.51 TFE 29.1 μM pH neutral CP1 
Time (hrs)
0.0 0.5 1.0 1.5 2.0 2.5
T
h
ic
k
n
e
s
s
 (
n
m
)
0
20
40
60
80
Crystal 1
Crystal 2
Crystal 3
Crystal 4
PB
25% TFE
C-P1 + 25% TFE
25% TFE
PB (Rinse)
 
 Figure 9.52 TFE 29.1 μM pH neutral CP1 
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 Figure 9.53 TFE 29.1 μM pH pH 9.2 CP1 
Time (hrs)
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4
T
h
ic
k
n
e
s
s
 (
n
m
)
0
20
40
60
80
Crystal 1
Crystal 2
Crystal 3
Crystal 4
PB
25% TFE
C-P1 + 25% TFE
25% TFE
PB (Rinse)
 
 Figure 9.54 TFE 29.1 μM pH pH 9.2 CP1 
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Appendix D: AFM Whisker Plot of Retraction Data 
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Figure 9.55 Whisker plot of the retraction pull-off distances.  Outliers were removed 
from overall averages 
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Appendix E: O-antigen and Core Groups for the  
13 E. coli Strains 
 
 
Figure 9.56 O-antigen and core group for the K12 strains 
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Figure 9.57 O-antigen and core group for O26:K60:H11 
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Figure 9.58 O-antigen and for O35:H10 
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Figure 9.59 O-antigen and core group for O55:H7 
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Figure 9.60 O-antigen and core group for O113:H4 and O113:H21 
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Figure 9.61 O-antigen and core groupfor O117:K98:H4 
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Figure 9.62 O-antigen and core group for O157:H7, O157:H12, and O157:H16 
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Figure 9.63 O-antigen and core group for O172:H-
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Appendix F: AFM Retraction Force Data 
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 Figure 9.64 Glass slide AFM analysis 
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 Figure 9.65 HB101 AFM Analysis 
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 Figure 9.66 K12 AFM Analyses 
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 Figure 9.67 ML35 AFM Analyses 
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 Figure 9.68 O26:K60:H11 AFM Analyses 
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 Figure 9.69 O35:H10 AFM Analyses 
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Figure 9.70 O55:H7 AFM Analyses 
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Figure 9.71 O113:H4 AFM Analyses 
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Figure 9.72 O113:H21 AFM Analyses 
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Figure 9.73 O117:K98:H4 AFM Analyses 
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Figure 9.74 O157:H7 AFM Analyses 
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Figure 9.75 O157:H12 AFM Analyses 
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Figure 9.76 O157:H16 AFM Analyses 
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Figure 9.77 O172:H- AFM Analyses 
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Appendix G: Approach and Retraction Force Plots 
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Figure 9.78 5 force plots of HB101 to silicon nitride 
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Figure 9.79 5 force plots of HB101 to silicon nitride 
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Figure 9.80 5 force plots of HB101 to silicon nitride 
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Figure 9.81 5 force plots of HB101 to silicon nitride 
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Figure 9.82 5 force plots of HB101 to silicon nitride 
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Figure 9.83 5 force plots of HB101 to silicon nitride 
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Figure 9.84 5 force plots of HB101 to silicon nitride 
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Figure 9.85 5 force plots of HB101 to silicon nitride 
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Figure 9.86 5 force plots of HB101 to silicon nitride 
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Figure 9.87 5 force plots of HB101 to silicon nitride 
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Figure 9.88 5 force plots of HB101 to CP1 
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Figure 9.89 5 force plots of HB101 to CP1 
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Figure 9.90 5 force plots of HB101 to CP1 
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Figure 9.91 5 force plots of HB101 to CP1 
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Figure 9.92 5 force plots of HB101 to CP1 
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Figure 9.93 5 force plots of HB101 to CP1 
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Figure 9.94 5 force plots of HB101 to CP1 
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Figure 9.95 5 force plots of HB101 to CP1 
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Figure 9.96 5 force plots of HB101 to CP1 
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Figure 9.97 5 force plots of HB101 to CP1 
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Figure 9.98 5 force plots of K12 to silicon nitride 
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Figure 9.99 5 force plots of K12 to silicon nitride 
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Figure 9.100 5 force plots of K12 to silicon nitride 
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Figure 9.101 5 force plots of K12 to silicon nitride 
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Figure 9.102 5 force plots of K12 to silicon nitride 
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Figure 9.103 5 force plots of K12 to silicon nitride 
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Figure 9.104 5 force plots of K12 to silicon nitride 
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Figure 9.105 5 force plots of K12 to silicon nitride 
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Figure 9.106 5 force plots of K12 to silicon nitride 
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Figure 9.107 5 force plots of K12 to silicon nitride 
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Figure 9.108 5 force plots of K12 to CP1 
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Figure 9.109 5 force plots of K12 to CP1 
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Figure 9.110 5 force plots of K12 to CP1 
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Figure 9.111 5 force plots of K12 to CP1 
 
 
Section 9                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
218 
Separation Distance (nm)
0 200 400 600
F
o
rc
e
 (
n
N
)
-2
-1
0
1
2
Approach Curves
Retraction Curves
 
 
Figure 9.112 5 force plots of K12 to CP1 
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Figure 9.113 5 force plots of K12 to CP1 
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Figure 9.114 5 force plots of K12 to CP1 
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Figure 9.115 5 force plots of K12 to CP1 
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Figure 9.116 5 force plots of K12 to CP1 
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Figure 9.117 5 force plots of K12 to CP1 
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Figure 9.118 5 force plots of ML35 to silicon nitride 
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Figure 9.119 5 force plots of ML35 to silicon nitride 
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Figure 9.120 5 force plots of ML35 to silicon nitride 
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Figure 9.121 5 force plots of ML35 to silicon nitride 
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Figure 9.122 5 force plots of ML35 to silicon nitride 
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Figure 9.123 5 force plots of ML35 to silicon nitride 
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Figure 9.124 5 force plots of ML35 to silicon nitride 
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Figure 9.125 5 force plots of ML35 to silicon nitride 
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Figure 9.126 5 force plots of ML35 to silicon nitride 
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Figure 9.127 5 force plots of ML35 to silicon nitride 
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Figure 9.128 5 force plots of ML35 to CP1 
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Figure 9.129 5 force plots of ML35 to CP1 
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Figure 9.130 5 force plots of ML35 to CP1 
 
 
 
 
 
Figure 9.131 5 force plots of ML35 to CP1 
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Figure 9.132 5 force plots of ML35 to CP1  
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Figure 9.133 5 force plots of ML35 to CP1 
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Figure 9.134 5 force plots of ML35 to CP1 
 
 
 
 
 
 
Figure 9.135 5 force plots of ML35 to CP1 
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Figure 9.136 5 force plots of ML35 to CP1 
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Figure 9.137 5 force plots of ML35 to CP1 
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Figure 9.138 5 force plots of O26:K60:H11 to silicon nitride 
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Figure 9.139 5 force plots of O26:K60:H11 to silicon nitride 
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Figure 9.140 5 force plots of O26:K60:H11 to silicon nitride 
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Figure 9.141 5 force plots of O26:K60:H11 to silicon nitride 
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Figure 9.142 5 force plots of O26:K60:H11 to silicon nitride 
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Figure 9.143 5 force plots of O26:K60:H11 to silicon nitride 
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Figure 9.144 5 force plots of O26:K60:H11 to silicon nitride 
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Figure 9.145 5 force plots of O26:K60:H11 to silicon nitride 
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Figure 9.146 5 force plots of O26:K60:H11 to silicon nitride 
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Figure 9.147 5 force plots of O26:K60:H11 to silicon nitride 
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Figure 9.148 5 force plots of O26:K60:H11 to CP1 
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Figure 9.149 5 force plots of O26:K60:H11 to CP1 
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Figure 9.150 5 force plots of O26:K60:H11 to CP1 
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Figure 9.151 5 force plots of O26:K60:H11 to CP1 
 
 
 
Section 9                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
238 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.152 5 force plots of O26:K60:H11 to CP1 
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Figure 9.153 5 force plots of O26:K60:H11 to CP1 
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Figure 9.154 5 force plots of O26:K60:H11 to CP1 
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Figure 9.155 5 force plots of O26:K60:H11 to CP1 
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Figure 9.156 5 force plots of O26:K60:H11 to CP1 
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Figure 9.157 5 force plots of O26:K60:H11 to CP1 
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Figure 9.158 5 force plots of O35:H10 to silicon nitride 
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Figure 9.159 5 force plots of O35:H10 to silicon nitride 
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Figure 9.160 5 force plots of O35:H10 to silicon nitride 
 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.161 5 force plots of O35:H10 to silicon nitride 
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Figure 9.162 5 force plots of O35:H10 to silicon nitride 
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Figure 9.163 5 force plots of O35:H10 to silicon nitride 
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Figure 9.164 5 force plots of O35:H10 to silicon nitride 
 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.165 5 force plots of O35:H10 to silicon nitride 
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Figure 9.166 5 force plots of O35:H10 to silicon nitride 
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Figure 9.167 5 force plots of O35:H10 to silicon nitride 
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Figure 9.168 5 force plots of O35:H10 to CP1 
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Figure 9.169 5 force plots of O35:H10 to CP1 
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Figure 9.170 5 force plots of O35:H10 to CP1 
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Figure 9.171 5 force plots of O35:H10 to CP1 
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Figure 9.172 5 force plots of O35:H10 to CP1 
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Figure 9.173 5 force plots of O35:H10 to CP1 
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Figure 9.174 5 force plots of O35:H10 to CP1 
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Figure 9.175 5 force plots of O35:H10 to CP1 
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Figure 9.176 5 force plots of O35:H10 to CP1 
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Figure 9.177 5 force plots of O35:H10 to CP1 
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Figure 9.178 5 force plots of O55:H7 to silicon nitride 
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Figure 9.179 5 force plots of O55:H7 to silicon nitride 
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Figure 9.180 5 force plots of O55:H7 to silicon nitride 
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Figure 9.181 5 force plots of O55:H7 to silicon nitride 
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Figure 9.182 5 force plots of O55:H7 to silicon nitride 
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Figure 9.183 5 force plots of O55:H7 to silicon nitride 
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Figure 9.184 5 force plots of O55:H7 to silicon nitride 
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Figure 9.185 5 force plots of O55:H7 to silicon nitride 
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Figure 9.186 5 force plots of O55:H7 to silicon nitride 
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Figure 9.187 5 force plots of O55:H7 to silicon nitride 
 
 
 
 
Section 9                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
256 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.188 5 force plots of O55:H7 to CP1 
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Figure 9.189 5 force plots of O55:H7 to CP1 
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Figure 9.190 5 force plots of O55:H7 to CP1 
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Figure 9.191 5 force plots of O55:H7 to CP1 
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Figure 9.192 5 force plots of O55:H7 to CP1 
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Figure 9.193 5 force plots of O55:H7 to CP1 
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Figure 9.194 5 force plots of O55:H7 to CP1 
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Figure 9.195 5 force plots of O55:H7 to CP1 
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Figure 9.196 5 force plots of O55:H7 to CP1 
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Figure 9.197 5 force plots of O55:H7 to CP1 
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Figure 9.198 5 force plots of O113:H4 to silicon nitride 
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Figure 9.199 5 force plots of O113:H4 to silicon nitride 
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Figure 9.200 5 force plots of O113:H4 to silicon nitride 
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Figure 9.201 5 force plots of O113:H4 to silicon nitride 
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Figure 9.202 5 force plots of O113:H4 to silicon nitride 
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Figure 9.203 5 force plots of O113:H4 to silicon nitride 
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Figure 9.204 5 force plots of O113:H4 to silicon nitride 
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Figure 9.205 5 force plots of O113:H4 to silicon nitride 
 
 
 
Section 9                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
265 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.206 5 force plots of O113:H4 to silicon nitride 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.207 5 force plots of O113:H4 to silicon nitride 
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Figure 9.208 5 force plots of O113:H4 to CP1 
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Figure 9.209 5 force plots of O113:H4 to CP1 
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Figure 9.210 5 force plots of O113:H4 to CP1 
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Figure 9.211 5 force plots of O113:H4 to CP1 
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Figure 9.212 5 force plots of O113:H4 to CP1 
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Figure 9.213 5 force plots of O113:H4 to CP1 
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Figure 9.214 5 force plots of O113:H4 to CP1 
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Figure 9.215 5 force plots of O113:H4 to CP1 
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Figure 9.216 5 force plots of O113:H4 to CP1 
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Figure 9.217 5 force plots of O113:H4 to CP1 
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Figure 9.218 5 force plots of O113:H21 to silicon nitride 
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Figure 9.219 5 force plots of O113:H21 to silicon nitride 
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Figure 9.220 5 force plots of O113:H21 to silicon nitride 
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Figure 9.221 5 force plots of O113:H21 to silicon nitride 
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Figure 9.222 5 force plots of O113:H21 to silicon nitride 
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Figure 9.223 5 force plots of O113:H21 to silicon nitride 
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Figure 9.224 5 force plots of O113:H21 to silicon nitride 
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Figure 9.225 5 force plots of O113:H21 to silicon nitride 
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Figure 9.226 5 force plots of O113:H21 to silicon nitride 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.227 5 force plots of O113:H21 to silicon nitride 
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Figure 9.228 5 force plots of O113:H21 to CP1 
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Figure 9.229 5 force plots of O113:H21 to CP1 
 
 
 
Section 9                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
277 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.230 5 force plots of O113:H21 to CP1 
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Figure 9.231 5 force plots of O113:H21 to CP1 
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Figure 9.232 5 force plots of O113:H21 to CP1 
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Figure 9.233 5 force plots of O113:H21 to CP1 
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Figure 9.234 5 force plots of O113:H21 to CP1 
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Figure 9.235 5 force plots of O113:H21 to CP1 
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Figure 9.236 5 force plots of O113:H21 to CP1 
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Figure 9.237 5 force plots of O113:H21 to CP1 
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Figure 9.238 5 force plots of O117:K98:H4 to silicon nitride 
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Figure 9.239 5 force plots of O117:K98:H4 to silicon nitride 
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Figure 9.240 5 force plots of O117:K98:H4 to silicon nitride 
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Figure 9.241 5 force plots of O117:K98:H4 to silicon nitride 
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Figure 9.242 5 force plots of O117:K98:H4 to silicon nitride 
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Figure 9.243 5 force plots of O117:K98:H4 to silicon nitride 
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Figure 9.244 5 force plots of O117:K98:H4 to silicon nitride 
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Figure 9.245 5 force plots of O117:K98:H4 to silicon nitride 
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Figure 9.246 5 force plots of O117:K98:H4 to silicon nitride 
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Figure 9.247 5 force plots of O117:K98:H4 to silicon nitride 
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Figure 9.248 5 force plots of O117:K98:H4 to CP1 
 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.249 5 force plots of O117:K98:H4 to CP1 
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Figure 9.250 5 force plots of O117:K98:H4 to CP1 
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Figure 9.251 5 force plots of O117:K98:H4 to CP1 
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Figure 9.252 5 force plots of O117:K98:H4 to CP1 
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Figure 9.253 5 force plots of O117:K98:H4 to CP1 
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Figure 9.254 5 force plots of O117:K98:H4 to CP1 
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Figure 9.255 5 force plots of O117:K98:H4 to CP1 
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Figure 9.256 5 force plots of O117:K98:H4 to CP1 
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Figure 9.257 5 force plots of O117:K98:H4 to CP1 
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Figure 9.258 5 force plots of O157:H7 to silicon nitride 
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Figure 9.259 5 force plots of O157:H7 to silicon nitride 
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Figure 9.260 5 force plots of O157:H7 to silicon nitride 
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Figure 9.261 5 force plots of O157:H7 to silicon nitride 
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Figure 9.262 5 force plots of O157:H7 to silicon nitride 
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Figure 9.263 5 force plots of O157:H7 to silicon nitride 
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Figure 9.264 5 force plots of O157:H7 to silicon nitride 
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Figure 9.265 5 force plots of O157:H7 to silicon nitride 
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Figure 9.266 5 force plots of O157:H7 to silicon nitride 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.267 5 force plots of O157:H7 to silicon nitride 
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Figure 9.268 5 force plots of O157:H7 to CP1 
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Figure 9.269 5 force plots of O157:H7 to CP1 
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Figure 9.270 5 force plots of O157:H7 to CP1 
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Figure 9.271 5 force plots of O157:H7 to CP1 
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Figure 9.272 5 force plots of O157:H7 to CP1 
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Figure 9.273 5 force plots of O157:H7 to CP1 
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Figure 9.274 5 force plots of O157:H7 to CP1 
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Figure 9.275 5 force plots of O157:H7 to CP1 
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Figure 9.276 5 force plots of O157:H7 to CP1 
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Figure 9.277 5 force plots of O157:H7 to CP1 
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Figure 9.278 5 force plots of O157:H12 to silicon nitride 
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Figure 9.279 5 force plots of O157:H12 to silicon nitride 
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Figure 9.280 5 force plots of O157:H12 to silicon nitride 
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Figure 9.281 5 force plots of O157:H12 to silicon nitride 
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Figure 9.282 5 force plots of O157:H12 to silicon nitride 
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Figure 9.283 5 force plots of O157:H12 to silicon nitride 
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Figure 9.284 5 force plots of O157:H12 to silicon nitride 
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Figure 9.285 5 force plots of O157:H12 to silicon nitride 
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Figure 9.286 5 force plots of O157:H12 to silicon nitride 
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Figure 9.287 5 force plots of O157:H12 to silicon nitride 
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Figure 9.288 5 force plots of O157:H12 to CP1 
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Figure 9.289 5 force plots of O157:H12 to CP1 
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Figure 9.290 5 force plots of O157:H12 to CP1 
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Figure 9.291 5 force plots of O157:H12 to CP1 
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Figure 9.292 5 force plots of O157:H12 to CP1 
 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.293 5 force plots of O157:H12 to CP1 
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Figure 9.294 5 force plots of O157:H12 to CP1 
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Figure 9.295 5 force plots of O157:H12 to CP1 
 
 
 
Section 9                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
310 
Seperation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.296 5 force plots of O157:H12 to CP1 
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Figure 9.297 5 force plots of O157:H12 to CP1 
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Figure 9.298 5 force plots of O157:H16 to silicon nitride 
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Figure 9.299 5 force plots of O157:H16 to silicon nitride 
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Figure 9.300 5 force plots of O157:H16 to silicon nitride 
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Figure 9.301 5 force plots of O157:H16 to silicon nitride 
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Figure 9.302 5 force plots of O157:H16 to silicon nitride 
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Figure 9.303 5 force plots of O157:H16 to silicon nitride 
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Figure 9.304 5 force plots of O157:H16 to silicon nitride 
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Figure 9.305 5 force plots of O157:H16 to silicon nitride 
 
 
 
Section 9                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
315 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.306 5 force plots of O157:H16 to silicon nitride 
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Figure 9.307 5 force plots of O157:H16 to silicon nitride 
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Figure 9.308 5 force plots of O157:H16 to CP1 
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Figure 2.309 5 force plots of O157:H16 to CP1 
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Figure 9.310 5 force plots of O157:H16 to CP1 
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Figure 9.311 5 force plots of O157:H16 to CP1 
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Figure 9.312 5 force plots of O157:H16 to CP1 
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Figure 9.313 5 force plots of O157:H16 to CP1 
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Figure 9.314 5 force plots of O157:H16 to CP1 
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Figure 9.315 5 force plots of O157:H16 to CP1 
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Figure 9.316 5 force plots of O157:H16 to CP1 
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Figure 9.317 5 force plots of O157:H16 to CP1 
 
 
 
 
 
Section 9                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
321 
Separation Distance (nm)
0 200 400 600 800
F
o
rc
e
 (
n
N
)
-10
-8
-6
-4
-2
0
2
Approach Curves
Retraction Curves
 
Figure 9.318 5 force plots of O172:H- to silicon nitride 
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Figure 9.319 5 force plots of O172:H- to silicon nitride 
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Figure 9.320 5 force plots of O172:H- to silicon nitride 
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Figure 9.321 5 force plots of O172:H- to silicon nitride 
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Figure 9.322 5 force plots of O172:H- to silicon nitride 
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Figure 9.323 5 force plots of O172:H- to silicon nitride 
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Figure 9.324 5 force plots of O172:H- to silicon nitride 
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Figure 9.325 5 force plots of O172:H- to silicon nitride 
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Figure 9.326 5 force plots of O172:H- to silicon nitride 
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Figure 9.327 5 force plots of O172:H- to silicon nitride 
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Figure 9.328 5 force plots of O172:H- to CP1 
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Figure 9.329 5 force plots of O172:H- to CP1 
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Figure 9.330 5 force plots of O172:H- to CP1 
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Figure 9.331 5 force plots of O172:H- to CP1 
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Figure 9.332 5 force plots of O172:H- to CP1 
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Figure 9.333 5 force plots of O172:H- to CP1 
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Figure 9.334 5 force plots of O172:H- to CP1 
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Figure 9.335 5 force plots of O172:H- to CP1 
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Figure 9.336 5 force plots of O172:H- to CP1 
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Figure 9.337 5 force plots of O172:H- to CP1 
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Appendix H: Interfacial Free Energy Calculations 
    Table 9.1 E. coli Contact Angles 
 
          
  Contact angles1   
Bacterium 
    
  θ (°), n=9        
    E. coli HB101 E. coli K12 E. coli ML35  
  θW 63 ± 1 65 ± 2 67 ± 2  
  θD 65 ± 3 60 ± 1 63 ± 1  
  θF 52 ± 2 48 ± 1 50 ± 1  
    E. coli O157:H7 E. coli O157:H12 E. coli O157:H16  
  θW 70 ± 1 70 ± 1 58 ± 2  
  θD 48 ± 1 48 ± 1 80 ± 3  
  θF 41 ± 3 41 ± 3 81 ± 3  
    E. coli O55:H7 E. coli O113:H4 E. coli O35:K:H10  
  θW 70 ± 3 47 ± 2 60 ± 3  
  θD 75 ± 3 66.7 ± 2 72 ± 3  
  θF 77 ± 3 70 ± 2 78 ± 2  
    E. coli O113:H21 E. coli O117:K98:H4 E. coli O26:K60:H11  
  θW 56 ± 2 66 ± 1 54 ± 3  
  θD 75 ± 2 50 ± 1 80 ± 3  
  θF 78 ± 3 37 ± 1 78 ± 2  
    E. coli O172:H-     
  θW 68 ± 1     
  θD 48 ± 1     
  θF 41 ± 1      
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Surface energy 
components1 
  
Bacterium 
  
  (mJ/m2), n=9       
   E. coli HB101 E. coli K12 E. coli ML35 
  γbLw 20.598 23.843 22.447 
  γb- 19.228 14.401 13.246 
  γb+ 3.51 3.688 3.924 
  γbAB 16.43 14.576 14.418 
  γbTotal 37.028 38.42 36.865 
   E. coli O157:H7 E. coli O157:H12 E. coli O157:H16 
  γbLw 31.662 29.208 10.596 
  γb- 6.657 8.159 60.412 
  γb+ 3.498 3.674 0.046 
  γbAB 9.651 10.949 3.339 
  γbTotal 41.314 40.157 13.935 
   E. coli O55:H7 E. coli O113:H4 E. coli O35:K:H10 
  γbLw 14.518 15.853 14.443 
  γb- 31.672 66.477 52.222 
  γb+ 0.248 0.066 1.857 E-3 
  γbAB 5.605 4.18 0.623 
  γbTotal 20.122 20.033 15.066 
   E. coli O113:H21 E. coli O117:K98:H4 E. coli O26:K60:H11 
  γbLw 13.759 10.417 30.183 
  γb- 42.059 64.094 8.495 
  γb+ 0.098 0.178 4.508 
  γbAB 4.053 6.764 12.377 
  γbTotal 17.811 17.181 42.561 
   E. coli O172:H-    
  γbLw 31.259    
  γb- 8.326    
  γb+ 3.357    
  γbAB 10.573    
  γbTotal 41.832     
 
 
Table 9.2 SFE Components 
 
 
Section 9                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
333 
 
 
      
 Contact angles1 Substrate    
 θ (°), n=9      
   Gold 10 μm CP1-cys  
 θW 63 ± 1 39 ± 2  
 θD 65 ± 3 32 ± 3  
 θF 52 ± 2 53 ± 1  
     
 
       
 
Surface energy 
components Substrate 
  
 
 (mJ/m2), n=9      
    Gold 10 μm CP1-cys  
  γbLw 28.337 32.125  
  γb- 9.783 58.251  
  γb+ 1.01 8.853 E-3  
  γbAB 6.287 1.436  
  γbTotal 34.624 33.561  
     
 
 
 
      
 Contact angles1 Substrate    
 θ (°), n=9      
   Silicon Nitride 10 μm CP1  
 θW 54 ± 2 38 ± 2  
 θD 58 ± 1 48 ± 3  
 θF 34 ± 2 27 ± 1  
     
 
 
 
 
Table 9.3 Gold Contact Angles 
Table 9.4 Gold SFE Components 
Table 9.5 Silicon Nitride Contact Angles 
 
 
Section 9                             Investigating Pathogenic E. coli with Antimicrobial Peptides 
 
334 
 
 
       
 
Surface energy 
components Substrate 
  
 
 (mJ/m2), n=9      
    Silicon Nitride 10 μm CP1-cys  
  γbLw 20.719 27.365  
  γb- 56.409 35.303  
  γb+ 4.353 4.315  
  γbAB 31.341 24.684  
  γbTotal 52.06 52.049  
     
 
Table 9.6 Silicon Nitride SFE Components 
